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Abstract 
Proteins and RNA are biopolymers that form complex secondary and tertiary structures 
and perform catalysis in nature. Single-stranded DNA is structurally similar to RNA and is also 
capable of catalytic function. DNA enzymes, or deoxyribozymes, are not known to exist in nature, 
but they have been identified in lab by in vitro selection for a variety of chemical reactions. De 
novo identification of nucleic acid enzymes is possible because RNA and DNA can be amplified 
using the polymerase chain reaction. In contrast, there is no method to amplify proteins. Nucleic 
acids are uniquely suited for in vitro selection, because random sequences form secondary 
structures and do not aggregate, and because a relatively large fraction of sequence space can be 
explored when there are only four nucleic acid monomers. In vitro selection is a potent method to 
identify enzymes from scratch for reactions that do not have existing enzymes. For this purpose, 
DNA has additional advantages over RNA. DNA can be directly amplified without an extra reverse 
transcription step, and DNA is more stable and less expensive than RNA. 
The major disadvantage of nucleic acid enzymes compared to protein enzymes is the lack 
of side-chain functionality. Previous efforts in the Silverman lab attempted to mitigate this by 
installing protein-like functional groups on DNA using various modified dUTPs, which required 
a complicated synthetic preparation for each functional group. Chapter 2 describes the method of 
copper-catalyzed azide-alkyne cycloaddition (CuAAC) to install protein-like functional groups on 
alkyne-modified DNA. This modular method streamlines the preparative work and makes it easier 
to use a wide variety of functional groups for in vitro selection. 
Carbohydrates are a major class of biomolecules. The nonlinearity of carbohydrates leads 
to a much larger number of possible structures compared to proteins and nucleic acids of similar 
size. In addition, the non-templated biosynthesis of carbohydrates causes difficulty for both 
synthetic preparation and structural analysis. Glycosidases and glycosyltransferases are important 
components of the glycobiology toolbox that facilitate manipulation of complex carbohydrate 
structures. Chapter 3 describes the in vitro selection of deoxyribozymes for O-glycoside cleavage. 
N-glycosidase deoxyribozymes were reported nearly two decades ago, but O-glycosidase 
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deoxyribozymes are not known, and ultimately were not identified successfully in the research 
described in this thesis. Chapter 3 also describes how the challenge to identify O-glycosidase 
deoxyribozymes was approached from multiple angles, such as by introducing noncanonical 
functional groups and by tuning sugar substrate reactivity. Among other functional groups, we 
provided the DNA sequences with boronic acid for diol binding, and carboxylate acid to enable 
mimicking of the dicarboxylate catalytic pathway of protein glycosidases. We also used reactive 
aryl glycoside substrates in addition to a disaccharide substrate. The in vitro selection experiments 
were unsuccessful, and no deoxyribozymes were identified. 
The balance of substrate reactivity is delicate for many in vitro selection experiments. A 
high background reaction rate leaves little room for rate enhancement, while a low background 
reaction rate may indicate a difficult reaction for which the fraction of catalytic sequences in a 
random population is too low to be identified by in vitro selection. We explored substrate reactivity 
in the in vitro selection of deoxyribozymes for 3-nitrotyrosine azido-adenylylation described in 
Chapter 4. Previous research had identified deoxyribozymes for tyrosine azido-adenylylation. The 
hydroxyl group of 3-nitrotyrosine is many orders of magnitude less reactive than that of tyrosine. 
In addition to potential biochemical significance of 3-nitrotyrosine modification and detection in 
the presence of tyrosine, we were interested to see if catalytic DNA sequences were able to 
overcome the difficulty of a less reactive substrate and emerge during in vitro selection. The in 
vitro selection experiments were unsuccessful, and no deoxyribozymes were identified. 
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Chapter 1: Introduction to the Glycobiology Toolbox and Enzyme Catalysis 
1.1 Carbohydrates 
1.1.1 Biological Role of Carbohydrates 
Carbohydrates are a major class of biomolecules with diverse biological functions.1 
Monosaccharides and disaccharides are central metabolites in energy transfer. Polysaccharides 
such as glycogen serve as energy storage. Oligosaccharides attached to other biomolecules such 
as proteins function as molecular recognition units and participate in signaling and regulation.2 
Sugars can also serve as structural components, such as polysaccharides on proteoglycans, and 
ribose and deoxyribose in RNA and DNA. 
1.1.2 Carbohydrate Structure Diversity 
Polysaccharides have a larger possibility of possible structures compared to proteins and 
nucleic acids of similar size.3 Two contributing factors to structural diversity are the large number 
of stereoisomeric monosaccharide building blocks and the nonlinearity of polysaccharides. The 
formation of each glycosidic bond also leads to the creation of a new stereogenic center. As such, 
the theoretical number of possible structures increases at a rapid rate with each additional monomer. 
Glucose (D-Glc) is the most abundant monosaccharide in mammals. However, 
glucosamine (D-GlcNAc), galactose (D-Gal), and mannose (D-Man) comprise the majority (~75%) 
of building blocks in mammalian polysaccharide structures.3 
1.2 The Glycobiology Toolbox 
1.2.1 Analytical Methods 
The non-templated synthesis of carbohydrates and low concentrations of many sugar-
containing biomolecules provide a significant challenge for analysis. Polysaccharides obtainable 
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in large quantities are commonly hydrolyzed to smaller oligosaccharides or monosaccharide 
components for chromatography and mass spectrometry analysis.4-8 NMR spectroscopy can also 
be useful in structural assignments.9 
1.2.2 Carbohydrate Building Blocks 
Despite the astronomical number of theoretically possible oligosaccharide structures, only 
a small fraction of them are biologically relevant. A relatively small number of building blocks is 
sufficient to access a wide range of biologically relevant oligosaccharides by organic synthesis via 
chemical glycosylation methods (Figure 1.1).3,10 Many of the building blocks are commercially 
available. 
 
Figure 1.1. An example of a monosaccharide building blocks library for synthetic preparation of 
common oligosaccharides. Figure reprinted with permission from ref. 3. 
The disadvantage of chemical glycosylation is the required usage of protecting groups, 
which necessitate multiple protecting and deprotecting steps during synthesis. Stereocontrol is also 
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a significant challenge, since the formation of the anomeric stereocenter is nonspecific using 
chemical methods.11 One common strategy uses neighboring group participation of the carbonyl 
functionality on the C2 hydroxyl or amino group (Figure 1.2).12,13 The oxygen of the carbonyl 
attacks the anomeric carbon, forming a five-membered ring as the glycosyl donor. The glycosyl 
acceptor can only approach the anomeric carbon from the other side, thus forming the β-product 
in a stereocontrolled manner. 
 
Figure 1.2. Stereospecific chemical glycosylation achieved by using neighboring group 
participation. Figure reprinted with permission from ref. 13. 
1.2.3 Enzymatic Synthesis 
Enzymatic synthesis provides an alternative method for the preparation of desired 
oligosaccharides.14-16 A highly selective enzymatic reaction eliminates the need for protecting 
groups on non-participatory hydroxyl groups and also provides stereospecific glycosylation. A 
major limitation of this approach is the requirement for the enzyme to be readily expressed and 
catalytically active under in vitro conditions. Many glycosyltransferases are membrane proteins 
and not soluble in vitro, and therefore of limited practical use.17 
The preparation of an oligosaccharide from its individual monosaccharide building blocks 
can be viewed as a bottom-up approach. A top-down approach is also available by enzymatic 
synthesis, where a complex oligosaccharide comprising in part the desired sugar is isolated from 
natural sources and trimmed to give the product.18 Glycosidases allows for specific glycosidic 
bonds to be targeted for hydrolysis in the presence of other glycoside linkages. This approach is 
greatly limited using chemical methods, since hydrolysis of glycosidic bonds is largely 
nondiscriminatory using acid hydrolysis.19 
4 
 
1.3 Natural Enzymes 
1.3.1 Protein Enzymes 
Enzymes are macromolecular catalysts used in nature to achieve desired chemical reactions. 
Substrate specificity and rate enhancement are two defining characteristics of enzymes. The 
majority of enzymes are protein enzymes, which make use of the rich functionality of amino acid 
side chains (Figure 1.3) for substrate binding and catalysis. The function of a protein is determined 
by its primary, secondary, tertiary, and quaternary structure. The primary structure of a protein is 
its amino acid sequence. Certain amino acid sequences form secondary structures such as α-helices 
and β-sheets, which interact to form tertiary structures. Protein enzymes fold into complex three-
dimensional structures, which are critical for catalytic activity. Multiple protein subunits can 
interact to form quaternary structures. 
 
Figure 1.3. Structures of the amino acid side chains and protein backbone. 
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1.3.1.1 Protein Glycosidases 
Protein glycosidases generally have large rate enhancement values that can reach up to 
1017-fold.20 The vast majority of glycosidases proceed through one of two possible dicarboxylate 
catalytic pathways (Figure 1.4). The stereochemistry at the anomeric carbon is inverted in the one-
step mechanism (a), while it is retained in the two-step, double-displacement mechanism (b).21,22 
 
Figure 1.4. Dicarboxylate catalytic pathways for protein glycosidases. (a) The inversion 
mechanism. (b) The retention mechanism. Figure reprinted with permission from ref. 21. 
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In the inversion mechanism, both catalytic residues participate in general acid-base 
catalysis. The residues are almost always amino acids with carboxylate side chains (Asp or Glu). 
In the retention mechanism, one of the residues acts instead as a nucleophile, which can 
occasionally be an amino acid other than Asp or Glu that has a suitable nucleophilic atom, such as 
Tyr or His.23 Both mechanisms involve an oxocarbenium-like transition state with a partial positive 
charge on the anomeric carbon. 
As seen in Figure 1.3, the hexose ring is significantly distorted during the catalytic 
process.24 The transition state can be mimicked with the natural envelope conformation of five-
membered rings. A variety of transition state analogs containing five-membered rings have been 
developed as glycosidase inhibitors, with Ki values in 0.1 to 1 nM range.25,26 
In addition to inverting and retaining glycosidases, some glycosidases have more esoteric 
modes of action.27,28 One group of unusual glycosidases uses NAD+ as a cofactor (Figure 1.5). The 
hydroxyl group on C3 is oxidized by NAD+ to a keto group. This acidifies the proton on C2, 
enabling elimination across the C1-C2 bond via an E1cb mechanism. Water adds across the double 
bond and the keto group is reduced by NADH, regenerating NAD+, with the net result being 
glycoside hydrolysis. 
The key differences of this mechanism from the inversion and retention mechanisms 
include the buildup of a negative charge on the pyranose ring (as opposed to formation of an 
oxocarbenium-like species, which builds up positive charge), and the involvement of both NAD+ 
and a divalent metal ion (usually Mn2+) as cofactors. 
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Figure 1.5. Mechanism of NAD+-dependent glycosidases. Figure reprinted with permission from 
ref. 28. 
Another group of unusual glycosidases works by catalyzing the excision at an interior 
uronic acid residue via a similar E1cb mechanism (Figure 1.6).28 The proton on C5 is naturally 
acidic due to its α-position relative to the C6 uronic acid. Elimination across the C4-C5 bond is 
catalyzed by an endoglycosidase, leading to glycoside cleavage. As with the previous NAD+-
dependent mechanism, a negative charge is present on the pyranose ring during the elimination 
step. 
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Figure 1.6. Mechanism of endoglycosidases that cleave at uronic acids. Figure reprinted with 
permission from ref. 28. 
1.3.2 Ribozymes 
 Although less common than protein enzymes, certain RNA sequences also possess 
catalytic activity; such enzymes are called ribozymes.29,30 RNA with catalytic activity was 
discovered in the early 1980s.31,32 The side-chain functionality of RNA is significantly limited 
compared to proteins (Figure 1.7), but a number of posttranscriptional modifications enhance RNA 
functional diversity.33 In addition, the negatively charged phosphate backbone can bind to metal 
ions. This helps define structure for RNA, which is critical for catalytic activity.34,35 Similar to 
proteins, RNA also forms secondary and tertiary structures. Secondary structures of RNA include 
helices and loops, which interact to form tertiary structures. 
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Figure 1.7. Structures of the RNA backbone and nucleobases. The side-chain diversity is limited 
compared to Figure 1.3 for amino acid side chains. 
Naturally occuring ribozymes have been discovered for a variety of reactions involving 
RNA processing, such as RNA splicing and cleavage.36,37 They can also form RNA-protein 
catalytic complexes such as the ribosome,38 in which the RNA catalyzes the peptidyl transfer 
during protein translation. 
1.4 Engineered and Artificial Enzymes 
1.4.1 Directed Evolution of Protein Enzymes 
Directed evolution is a method to identify protein enzymes with desired catalytic functions 
from existing enzymes.39 The existence of a parent enzyme is a requirement. Directed evolution 
can be used to improve rate enhancement, yield, or to change substrate specificity. Mutants of the 
parent enzyme are generated and screened for the targeted catalytic function. For directed 
evolution studies where new substrate specificity is desired, this often leads to identifying enzymes 
with relaxed substrate specificity that accommodate both the original substrate of the parent 
enzyme and the targeted substrate, instead of specificity for only the targeted substrate.40,41 
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1.4.2 De Novo Enzyme Design 
Using computational methods along with a fundamental understanding of active site 
catalytic mechanisms, it is possible to attempt to design an enzyme from scratch.42 The key active 
site residues are chosen based on the desired reaction mechanism and grafted onto a known protein 
scaffold to position them correctly in three-dimensional space. De novo enzyme design is often 
combined with directed evolution of the initial artificial protein to obtain robust catalytic activity.43 
The difficulty of rational enzyme design is reflected in the observation that the function of key 
residues in the final enzyme may not match their intended design, and residues in the scaffold can 
end up participating in catalysis. 
1.4.3 Development of Deoxyribozymes 
1.4.3.1 In Vitro Selection 
RNA and DNA with catalytic activity were identified in the laboratory via in vitro 
selection.44,45 In vitro selection (Figure 1.8) is the experimental process by which nucleic acids 
sequences with a targeted catalytic function are identified from a large population of random 
sequences (typically 1014 molecules).46 
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Figure 1.8. Schematic representation of the in vitro selection process. Only a very small fraction 
of sequences in the initial population is catalytically active (indicated by the red dots among the 
gray dots). The selection step separates the catalytically active sequences from the majority of the 
population. The PCR amplification step regenerated a sufficient population size for the next 
selection step. 
The in vitro selection of deoxyribozymes can be gel-based or bead-based. For gel-based in 
vitro selection, a mass difference is introduced to catalytically active sequences, which are 
separated from the population by polyacrylamide gel electrophoresis (PAGE) based on mass 
(Figure 1.9). For bead-based in vitro selection, the catalytically active sequences bind to the beads 
and are eluted after the population. The size of the population is regenerated sufficiently by PCR 
amplification, and the process is iterated until the desired catalytic activity dominates the pool of 
DNA sequences. 
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Figure 1.9. Schematic representation of gel-based in vitro selection of O-glycosidase 
deoxyribozymes. The sugar is depicted as the open-chain aldehyde form after hydrolysis. The mass 
difference is introduced by a splint-assisted hydrazide capture step, which is the basis for PAGE 
separation of catalytically active DNA sequences. 
The PCR amplification step is critical to performing in vitro selection. Since there is no 
method to amplify proteins, in vitro selection of proteins cannot be done as there will be close to 
no material left to work with after a single selection step. 
One disadvantage of DNA compared to proteins is the limited functional groups on DNA 
side chains (Figure 1.10), which may be a limitation for DNA to catalyze complex reactions. In 
addition, deoxyribozymes identified via an in vitro selection process are not optimized for turnover, 
which could be a potential limitation for future applications. 
 
Figure 1.10. Structures of the DNA backbone and nucleobases. 
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1.4.3.2 Catalytic Reactions of Deoxyribozymes 
The first deoxyribozyme was discovered in 1994 and catalyzes the cleavage of a single 
ribonucleotide embedded in a DNA substrate.45 Deoxyribozymes have since been identified for a 
variety of reactions, both with nucleic acid substrates and other bioorganic substrates. Reactions 
involving nucleic acid substrates include RNA/DNA ligation,47−50 RNA cleavage,51−53 DNA 
cleavage,54−57 DNA phosphorylation.58,59 and formation of nucleopeptide linkages.60−65 In 
particular, DNA cleavage can occur via hydrolysis,54,55 deglycosylation,56 or radical formation.57 
Other reactions include peptide side-chain phosphorylation,66,67 dephosphorylation,68 and azido-
adenylylation;69 reductive amination,70 ester hydrolysis,71 anilide hydrolysis,71 amide hydrolysis,72 
dehydroalanine formation,73 glycosylation,74 and amine acylation (Tianjiong Yao, unpublished 
results). 
Structure analysis of deoxyribozymes is difficult and has not been a great priority since it 
does not directly inform the design of in vitro selection. Currently there are only two crystal 
structures of existing deoxyribozymes, the 9DB1 deoxyribozyme for RNA ligation (Figure 1.11),75 
and the 8-17 deoxyribozyme for RNA cleavage.76 
 
Figure 1.11. The 9DB1 deoxyribozyme. (A) The RNA ligation reaction catalyzed by 9DB1. (B) 
Crystal structure of 9DB1. The ligation site is indicated in purple. (C) Key nucleic acid residues 
in the active site of 9DB1. Figures reprinted with permission from ref. 46 and ref. 75. 
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1.4.3.3 Deoxyribozymes with Artificial Functional Groups 
Proteins are uniquely suited to serve as enzymes due to the myriad of side-chain functional 
groups. The presence of acidic Asp and Glu and basic Lys and Arg residues cover a suitable range 
of pKa values and enable acid-base chemistry in catalysis. In contrast, the nucleobases of RNA and 
DNA are uncharged under physiological conditions. It is possible that the fraction of DNA 
sequences that are catalytically active in a random population is simply too low for more difficult 
reactions, which hinders the identification of deoxyribozymes by in vitro selection. 
The functional group diversity of DNA during in vitro selection can be increased by using 
modified nucleotides. A number of modified deoxyuridines were used successfully during in vitro 
selection of deoxyribozymes for amide bond hydrolysis (Figure 1.12),72 where in vitro selection 
with regular nucleotides failed to give activity. 
 
Figure 1.12. Modified nucleic acid residues with protein-like side chains that led to the 
identification of amide hydrolysis deoxyribozymes. 
1.5 Thesis Research Focus 
This thesis discusses the in vitro selection of deoxyribozymes for two reactions, O-
glycoside cleavage. Chapter 2 describes the methodology of copper-catalyzed azide-alkyne 
cycloaddition (CuAAC) to install functional groups on DNA. This is an alternative method to the 
previous approach of using various deoxyuridine and deoxycytidine derivatives during DNA 
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synthesis to introduce additional functional groups on DNA for in vitro selection. Instead, a single 
alkyne modification is introduced during DNA synthesis, and the various functional groups are 
installed by CuAAC afterwards. Chapter 3 presents the in vitro selection of deoxyribozymes with 
O-glycosidase activity. Deoxyribozymes with N-glycosidase activity in the context of nucleobase 
cleavage are known, and we sought to identify deoxyribozymes that catalyze the more common 
form of sugar hydrolysis, which is the cleavage of the O-glycoside bond in a disaccharide. We also 
examined in vitro selection using more reactive aryl sugar substrates in combination with modified 
nucleotides using the CuAAC methodology described in Chapter 2. Ultimately, the in vitro 
selection experiments were unsuccessful, and no deoxyribozymes were identified. Chapter 4 
describes the in vitro selection of deoxyribozymes for 3-nitrotyrosine azido-adenylylation. This is 
an extension of Puzhou Wang’s work on peptide tyrosine azido-adenylylation,69 but for a less 
reactive substrate. The in vitro selection experiments were unsuccessful, and no deoxyribozymes 
were identified. 
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Chapter 2: Methodology of Copper-Catalyzed Azide-Alkyne Cycloaddition to 
Install Functional Groups on DNA for In Vitro Selection 
2.1 Introduction 
2.1.1 Noncanonical Functional Groups on DNA 
The comparative lack of DNA side-chain functionality relative to proteins potentially limits 
the range of reactions for which deoxyribozymes can be identified. Previous in vitro selection 
efforts for deoxyribozymes for peptide cleavage demonstrated that functional groups such as 
amino, hydroxyl, and carboxyl were critical to identifying deoxyribozymes for amide bond 
hydrolysis.1 This led us to hypothesize that incorporation of noncanonical functional groups would 
also assist in vitro selection of deoxyribozymes for O-glycosidic bond cleavage, which is also a 
challenging reaction. The desire to employ boronic acids as sugar-binding motifs led us to develop 
a modular approach using copper-catalyzed azide-alkyne cycloaddition (CuAAC) to install 
functional groups on DNA sequences. This approach has been generalized to other in vitro 
selection efforts in the Silverman lab. 
2.1.2 Modified Nucleotides for In Vitro Selection 
Peptide hydrolysis is a longstanding target of DNA catalysis, due to the importance of the 
peptide bond in biological systems. However, progress was difficult even with model substrates 
such as an amide embedded within a DNA strand.2 Recently, the incorporation of protein-like 
functional groups including amino, hydroxyl, and carboxyl on deoxyuridine (Figure 2.1) led to the 
identification of deoxyribozymes that catalyze amide bond cleavage.1 Our hypothesis is that 
additional functional groups can assist identification of catalytic DNA sequences in the process of 
in vitro selection, either by fundamentally enabling the DNA sequences to catalyze the targeted 
reaction, or by enhancing the rate of catalysis up to a level that allows for successful sequence 
enrichment and identification during the iteration process. Furthermore, certain DNA sequences 
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identified in this manner retain a significant level of activity even when the functionalized 
deoxyuridine derivatives are replaced with regular thymidines. 
 
Figure 2.1. Chemical structures of modified deoxyuridines used in the in vitro selection of amide 
bond cleaving deoxyribozymes.1 
The synthetic preparation of functionalized deoxyuridine 5′-triphosphate derivatives 
presents a significant bottleneck during the aforementioned process. An alternative, modular 
approach using convergent synthesis is highly desirable to keep the preparative procedure as 
efficient as possible. Instead of synthesizing each 5′-triphosphate individually, the desired 
modifications are prepared as azido-containing bifunctional small molecules and then linked to an 
all-purpose alkyne-modified dT derivative via CuAAC. This strategy facilitates a significant 
expansion of our repertoire of functional modifications on DNA. 
2.1.3 CuAAC in SELEX 
The modular functionalization of DNA was previously reported in the context of 
systematic evolution of ligands by exponential enrichment (SELEX) for DNA aptamers (Figure 
2.2).3 An alkyne-modified random pool of DNA sequences was prepared by replacing thymidine 
with 5-ethynyl-2′-deoxyuridine (EdU). The functionalization of the DNA sequences with the 
desired moieties was performed in a separate CuAAC step using bifunctional azide compounds, 
most of which contained hydrophobic structures to help the DNA sequences bind the peptide 
targets via hydrophobic interactions. Critically, the noncanonical nucleotides must be compatible 
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with all steps that involve extension by a DNA polymerase, which are integral parts of the in vitro 
selection process. The frequently used Taq polymerase does not tolerate the modified nucleotides, 
but certain polymerases such as Pwo and KOD XL accept the modifications. 
 
Figure 2.2. Schematic representation of the click-SELEX strategy. (a) EdU embedded within the 
DNA strands are functionalized with a range of bifunctional azides. (b) Random pool design. (c) 
Iterative process of SELEX includes a CuAAC step. Figure reprinted with permission from ref. 3. 
2.2 Incorporating CuAAC in the In Vitro Selection Process 
2.2.1 Adjustments to the In Vitro Selection Process 
Functional group incorporation via CuAAC requires a number of adjustments to the basic 
in vitro selection process (Figure 1.9). Modified sequences containing EdU are linearly amplified 
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by primer extension on reverse-complement templates, and CuAAC is used to incorporate the 
desired functional groups (Figure 2.3). During subsequent iterations of the in vitro selection 
process, the unmodified reverse-complement templates are generated exponentially by PCR. KOD 
XL polymerase is used in place of Taq polymerase and is compatible with both the primer 
extension step and the PCR step. 
 
Figure 2.3. Overview of the in vitro selection process including a CuAAC step. The CuAAC 
functionalization step is shown on the upper left, with the modular modifications depicted in 
orange. Glycoside hydrolysis is shown as the targeted reaction as an example, with the sugar rings 
depicted schematically in pink; this strategy can be generalized to other reactions with slight 
alterations. 
2.2.2 Using 5-Ethynyl-2′-Deoxyuridine 5′-Triphosphate to Install Alkyne Moieties 
 EdU was incorporated by primer extension on reverse-complement templates using KOD 
XL polymerase and 5-ethynyl-2′-deoxyuridine 5′-triphosphate (EdUTP) in place of dTTP in the 
dNTP mixture. Primer extension was performed on three mock templates containing stretches of 
one, two, or three deoxyadenosines respectively, to ensure that KOD XL polymerase is able to 
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incorporate consecutive EdUTPs without issue (Figure 2.4). In addition, control experiments with 
regular dTTP showed that EdUTP did not have a detrimental effect on the primer extension yield 
(Figure 2.5). 
  
Figure 2.4. Primer extension on mock templates. The sequences of mock templates MT1 to MT3 
are shown on the left, with the six deoxyadenosines in the primer extension region highlighted in 
bold. The primer binds to the underlined regions. The similar yields across all three mock templates 
indicate no observable detrimental effect to having a string of two to three deoxyadenosines. 
 
Figure 2.5. Comparison of primer extension yields between using natural dNTPs versus using 
EdUTP in place of dTTP on an 89 nt reverse complement template with a 40 nt random region. 
The yields are approximately identical. 
2.2.3 Bifunctional Azide Compounds 
Bifunctional azide compounds are an integral component of the CuAAC strategy. They 
obviate the need for synthetic preparation of specific modified dUTPs, which is a significantly 
more complicated procedure in part due to the difficulty and low yield of the triphosphorylation 
step (Figure 2.6). The azides are generally straightforward to prepare by SN2 displacement of the 
corresponding bromide precursors. 
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Figure 2.6. A comparison between the linear (top) and convergent (bottom) synthetic routes to 
prepare functionalized DNA sequences. The convergent route produces a higher yield in fewer 
overall steps. 
2.2.3.1 Functional Modifications for O-Glycosidase Deoxyribozymes 
Previous efforts to find O-glycosidase deoxyribozymes with natural nucleotides were 
unsuccessful (Chapter 3.2). The ability to introduce additional functional groups allowed us to 
address the challenge from two angles, substrate binding and catalysis. We introduced two 
modifications in separate in vitro selection experiments using the CuAAC strategy, boronic acid 
and carboxylic acid (Figure 2.7). The boronic acid modification was introduced to help the DNA 
sequences better engage the sugar substrates, while the carboxylate modification was introduced 
to provide the DNA sequences the means to mimic the active site of protein glycosidases. 
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Figure 2.7. Bifunctional azides chosen for CuAAC incorporation during in vitro selection efforts 
for O-glycosidase deoxyribozymes. 
DNA aptamers have difficulty engaging carbohydrate structures such as oligosaccharides 
and glycoproteins.6 In recent years, researchers have turned to the diol-binding boronic acid as a 
potential solution.7 Boronic acids are used as sensor components for sugars and as solid-phase 
binding components for diols in chromatography. They have been incorporated in DNA aptamer 
studies targeting glycoproteins.6 Of the various diols, the affinity ranking for boronic acids is cis-
1,2-diol > 1,3-diol >> trans-1,2-diol. 
Naturally occurring protein glycosidases typically proceed via a dicarboxylate catalytic 
pathway (Figure 2.8).8 The presence of divalent metal ions in the in vitro selection process may 
enable certain DNA sequences to mimic the dicarboxylate pathway via the use of metal-bound 
water. While no evidence suggests that it is necessary or even advantageous for any O-glycosidase 
deoxyribozymes to follow the same catalytic mechanism, we reason that allowing for the 
possibility is a positive factor, and that providing the DNA sequences with access to carboxylate 
functional groups may facilitate the emergence of sequences that do require the dicarboxylate 
catalytic pathway during in vitro selection. 
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Figure 2.8. Predominant protein enzyme mechanisms for glycosidic bond cleavage, both of which 
use two carboxylate side chains in the active site. Figure reprinted with permission from ref. 8.  
2.2.4 CuAAC to Install Functional Groups 
Gel-shift assays were performed to monitor the CuAAC reaction efficiency on a model 36 
nt oligonucleotide containing six EdU sites (Figure 2.9), using 4-(azidomethyl)phenylboronic acid 
(Figure 2.7) as the azide compound. Incubation time was kept to a brief 1 h period to prevent 
possible DNA degradation by Cu+.9 Comparison between the single-CuAAC and double-CuAAC 
trials shows that the yield of single-CuAAC is quantitative, and therefore two consecutive CuAAC 
reactions are unnecessary. The product bands are upshifted due to the six boronic acid 
modifications, which corresponds to a mass increase of (177 × 6) / 11108 = 9.6%. 
31 
 
 
Figure 2.9. Gel shift assay of CuAAC on a model alkyne-containing oligonucleotide. The 
sequence of the alkyne oligo is 5′-CGAATTAAGACTGAATTCUAGUACUGAUGAUACUCC-3′, where 
the six bolded Us represent EdUs. It was prepared by primer extension using EdUTP and MT1 
(Figure 2.4) as the reverse-complement template. 
2.3 Summary 
The incorporation of 5-ethynyl-2′-deoxyuridine has led to a modular and streamlined 
approach to incorporate additional functional groups during the in vitro selection process. Beyond 
O-glycosidic bond cleavage, this strategy has been expanded to in vitro selection for peptide 
hydrolysis (Figure 2.10). Furthermore, the use of trifunctional azide molecules provides an 
efficient method of introducing multiple functionalities in a compact manner to facilitate both 
binding and catalysis. 
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Figure 2.10. Overview of the current bifunctional and trifunctional azide compounds used in the 
Silverman lab. Moieties designed for substrate binding are colored blue, whereas functional groups 
that may participate in either binding or catalysis are colored red. Azides other than 4-
(azidomethyl)phenylboronic acid and 3-azidopropionic acid were prepared by Cong Zhou for in 
vitro selection for peptide hydrolysis.4 
2.4 Materials and Methods 
2.4.1 Preparation of Oligonucleotide Substrates 
DNA oligonucleotides were purchased from Integrated DNA Technologies (Coralville, IA) 
or prepared by solid-phase synthesis on an ABI 394 instrument using reagents purchased from 
Glen Research. All oligonucleotides were purified by 7 M urea denaturing polyacrylamide gel 
electrophoresis (PAGE) with 1× TBE (89 mM each of Tris and boric acid, 2 mM EDTA, pH 8.3), 
extracted from polyacrylamide with TEN buffer (10 mM Tris, pH 8.0, 1 mM EDTA, 300 mM 
NaCl) and precipitated with ethanol prior to use, as described previously.10,11 5-Ethynyl-dUTP 
(EdUTP) used in the primer extension was purchased from Baseclick GmbH (cat. no. BCT-08-L). 
Procedure for primer extension with 5-ethynyl-dUTP to generate initial random DNA 
pools for in vitro selection. A 50 μL sample was prepared containing 250 pmol of the synthesized 
reverse complement template, 500 pmol of forward primer, 15 nmol each of dATP, dCTP, dGTP, 
and EdUTP, 5 μL of 10× KOD XL polymerase buffer, and 1 μL of KOD XL polymerase (prepared 
by Silverman lab member Shannon Walsh). Primer extension was performed by cycling 4 times 
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in a PCR thermocycler according to the following program: 94 °C for 2 min, 4× (94 °C for 2 min, 
47 °C for 2 min, 72 °C for 60 min), 72 °C for 60 min. The resulting product was purified by 8% 
PAGE and carried on to the CuAAC reaction. 
Procedure for primer extension with 5-ethynyl-dUTP to regenerate pool size in subsequent 
in vitro selection rounds. A 25 μL sample was prepared containing trace amounts of the single-
stranded reverse complement template obtained from PCR amplification of the capture step, 50 
pmol of forward primer, 7.5 nmol each of dATP, dCTP, dGTP, and EdUTP, 10 μCi of α-32P-dCTP 
(800 Ci/mmol), 2.5 μL of 10× KOD XL polymerase buffer, and 0.5 μL of KOD XL polymerase. 
Primer extension was performed by cycling in a PCR thermocycler according to the following 
program: 94 °C for 2 min, 47 °C for 2 min, 72 °C for 60 min. The resulting product was purified 
by 8% PAGE and carried on to the CuAAC reaction. 
2.4.2 Organic Synthesis Procedures 
 Reagents were commercial grade and used without purification unless otherwise indicated. 
Thin-layer chromatography (TLC) was performed on silica gel plates precoated with fluorescent 
indicator. Visualization was done by UV light (254 nm) or anisaldehyde staining. NMR spectra 
were recorded on a Varian VXR 500 at the UIUC School of Chemical Sciences NMR Laboratory. 
Chemical shifts in parts per million (δ) are reported downfield from TMS (0 ppm) and referenced 
to the residual proton signals for CDCl3 (7.26 ppm), CD3OD (3.31 ppm), or DMSO-d6 (2.50 ppm). 
Apparent multiplicities of 1H NMR peaks are reported as s (singlet), d (doublet), t (triplet), q 
(quartet), or m (multiplet and overlapping spin systems), along with values for apparent coupling 
constants (J, Hz). Low-resolution ESI mass spectrometry data were obtained on a Waters Quattro 
at the UIUC School of Chemical Sciences Mass Spectrometry Laboratory. 
2.4.2.1 Synthesis of Bifunctional Azide Compounds 
Synthesis of 4-(azidomethyl)phenylboronic acid (4-AMPBA).5 To a solution of 4-
(bromomethyl)phenylboronic acid (Sigma-Aldrich, cat. no. 679437; 900 mg, 4.19 mmol) in 10 mL 
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of DMSO was added sodium azide (410 mg, 6.32 mmol), and the solution was stirred at room 
temperature overnight. The reaction was quenched by the addition of 25 mL of water, and the 
product was extracted with diethyl ether (50 mL each, 3×) and dried with sodium sulfate. The 
solvent was evaporated to yield the desired product as a white solid (509 mg, 68%). 
1H NMR: (500 MHz, DMSO-d6) δ 7.81 (d, J = 8.0 Hz, 2H), 7.35 (d, J = 8.0 Hz, 2H), 4.45 (s, 2H), 
2.55 (s, 2H) ppm. 
ESI-MS: m/z calcd. for C7H8N3O2B [M+HCOO]– 222.1; found 222.2. 
 Synthesis of 3-azidopropionic acid (3-APA).12 3-azidopropionic acid was prepared as 
described in ref. 12 and verified by ESI-MS. 
ESI-MS: m/z calcd. for C3H5N3O2 [M–H]– 114.03; found 114.03. 
2.4.3 CuAAC 
CuAAC with 4-AMPBA. DNA pools containing EdU were dissolved in water and brought 
to 10 μL total volume containing 100 mM HEPES, pH 7.5, 10 mM 4-AMPBA, 5 mM CuSO4, 10 
mM sodium ascorbate, and 40 mM tris(3-hydroxypropyltriazolylmethyl)amine (THPTA). 4-
AMPBA was prepared as a stock solution in DMSO because it was insufficiently soluble in water. 
The final concentration of DMSO in the reaction mixture was 10%. Stock solutions of THPTA 
(400 mM, 10×), sodium ascorbate (200 mM, 20×) and CuSO4 (100 mM, 20×) were premixed to 
produce Cu+ and added to the reaction mixture last. The sample was incubated at 37 °C for 1 h, 
then quenched by the addition of EDTA and precipitated with ethanol. 
CuAAC with 3-APA. Similar to above, DNA pools containing EdU were dissolved in water 
and brought to 10 μL total volume containing 100 mM HEPES, pH 7.5, 10 mM 3-APA, 5 mM 
CuSO4, 10 mM sodium ascorbate, and 40 mM THPTA. 3-APA was prepared as a stock solution 
in DMF for solubility reasons. The final concentration of DMF in the reaction mixture was 10%. 
Stock solutions of THPTA (400 mM, 10×), sodium ascorbate (200 mM, 20×) and CuSO4 (100 
mM, 20×) were premixed to produce Cu+ and added to the reaction mixture last. The sample was 
incubated at 37 °C for 1 h, then quenched by the addition of EDTA and precipitated with ethanol. 
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Chapter 3: In Vitro Selection of O-Glycosidase Deoxyribozymes 
3.1 Introduction 
3.1.1 Deoxyribozymes for N-Deglycosylation of DNA 
Previous research identified N-glycosidase deoxyribozymes that catalyze the depurination 
or depyrimidination of DNA.1,2 The first N-glycosidase deoxyribozymes were identified during in 
vitro selection targeting O-glycosidases.1 The design of the in vitro selection experiment aimed to 
identify O-glycosidases via strand scission caused by the cleavage of a disaccharide embedded 
within a DNA strand (Figure 3.1, blue arrow).3 The use of this substrate did not discriminate 
against DNA sequences that catalyze N-deglycosylation along the DNA strand itself (Figure 3.1, 
orange arrows), which leads to strand scission via a β-elimination pathway (Figure 3.2).1 In this 
instance, the in vitro selection process led only to the emergence of N-glycosidase deoxyribozymes. 
The stability of a nucleobase N-glycosidic bond is significantly lower than that of an O-glycosidic 
bond (spontaneous rate of hydrolysis at physiological conditions 10−9 min−1 versus 10−13 min−1),4,5 
which may be a contributing factor. 
 
Figure 3.1. Substrate used for in vitro selection of O-glycosidase deoxyribozymes. The bond 
targeted for cleavage is indicated by the blue arrow. N-deglycosylation can also occur along the 
DNA strands indicated by the orange arrows. Figure reprinted with permission from ref. 3. 
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Figure 3.2. Depurination of guanosine catalyzed by the 10-28 deoxyribozyme leads to DNA strand 
scission. Intermediate 1 is the DNA strand with an abasic site. Intermediate 2 is the initial strand 
scission product following β-elimination. A δ-elimination leads to the final product. Figure 
reprinted with permission from ref. 1. 
N-Glycosidase deoxyribozymes were also identified during in vitro selection of DNA 
hydrolysis deoxyribozymes.2 The experimental design was similarly based on strand scission, and 
both phosphodiesterase deoxyribozymes and N-deglycosylation deoxyribozymes emerged during 
the in vitro selection process (Figure 3.3), albeit with different metal ion cofactor requirements. 
It is important to note that the background reaction rates of two competing reactions are 
not the sole determining factors of the catalytic activity of deoxyribozymes that are identified by 
in vitro selection. As an example, previous in vitro selection efforts for peptide hydrolysis led 
instead to the identification of phosphodiester bond cleavage deoxyribozymes (Figure 3.4),6 
despite the much lower background rate for phosphodiester bond hydrolysis (kuncat = 10−14 min−1) 
compared to peptide bond hydrolysis (kuncat = 10−9 min−1).7 
39 
 
 
Figure 3.3. DNA sequences that catalyze DNA hydrolysis by either (a) phosphodiester bond 
cleavage or (b) N-deglycosylation both led to strand scission and were indistinguishable during 
the in vitro selection process. Figure reprinted with permission from ref. 2. 
 
Figure 3.4. Experimental design that led to the identification of deoxyribozymes for the cleavage 
of phosphodiester bonds, but not for the originally intended cleavage of amide bonds. Figure 
reprinted with permission from ref. 6. 
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3.1.2 Deoxyribozymes for O-Deglycosylation 
The emergence of solely N-glycosidase deoxyribozymes rather than O-glycosidase 
deoxyribozymes in previous efforts demonstrated that O-deglycosylation is a harder reaction for 
DNA to catalyze. Nevertheless, both deglycosylation reactions should proceed via a similar 
mechanism involving a reactive oxocarbenium intermediate or a transition state with significant 
oxocarbenium character on the anomeric carbon.8 Certain ribozymes are known to catalyze 
reactions with oxocarbenium intermediates (Figure 3.5), potentially stabilizing the oxocarbenium 
ion by negative charges on the phosphodiester backbone or by cation-π interactions. Therefore, 
DNA should possess the innate ability to catalyze O-glycosidic bond cleavage. We aimed to 
identify O-glycosidase activity specifically by designing an in vitro selection process to avoid the 
emergence of N-glycosidase activity. 
 
Figure 3.5. Possible mechanisms for ribozyme-promoted 4-thiouridine synthesis, involving  a 
reactive oxocarbenium intermediate (left) or a transition state with oxocarbenium character (right). 
Figure reprinted with permission from ref. 8. 
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3.1.3 Design of In Vitro Selection of O-Glycosidase Deoxyribozymes 
The process of in vitro selection of O-glycosidase deoxyribozymes is illustrated in Figure 
3.6. A glycoside substrate (either a disaccharide or an aryl glycoside) was conjugated to the end of 
a DNA anchor oligonucleotide. The aglycone leaving group is depicted as –OR. For the 
disaccharide substrate, the reducing end was protected as a methyl glycoside to prevent ring 
opening and formation of the open-chain aldehyde sugar. Cleavage of the O-glycosidic bond or 
the methyl glycoside leaves behind an unprotected reducing end that is in equilibrium with the 
open-chain aldehyde, providing a chemical handle for capture. The capture step is necessary to 
provide sufficient mass shift to separate catalytic sequences from noncatalytic sequences by PAGE. 
 
Figure 3.6. Schematic representation of the in vitro selection process of O-glycosidase 
deoxyribozymes. The sugar is depicted as the open-chain aldehyde form after hydrolysis. A large 
pool size was restored at the end of each round by PCR amplification if using natural nucleotides, 
or by PCR and primer extension if using modified nucleotides. 
When using the disaccharide substrate, one possibility is that we might identify 
deoxyribozymes that cleave the terminal methyl glycoside instead of the internal glycoside. This 
would be an acceptable initial outcome because these deoxyribozymes would also be O-
glycosidases. In any case, the internal glycosidic bond should be easier to cleave due to the 
resulting alkoxide leaving group being stabilized by neighboring electron-withdrawing hydroxyl 
groups and the formation of intramolecular hydrogen bonds. For example, the pKa of glucose is 
12, compared to 16 for the pKa of methanol.9 
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We prefer not to identify deoxyribozymes that perform N-glycosidic bond cleavage along 
the DNA anchor oligonucleotide, because this reaction is catalyzed by existing deoxyribozymes 
which have already been studied extensively. We aimed to circumvent this issue by installing a 
disulfide linkage within the DNA anchor oligonucleotide. Performing disulfide cleavage by DTT 
after the splint-assisted capture step allowed us to target cleavage that occurs specifically at the 
glycoside substrate. 
3.2 Results and Discussion 
Six sets of in vitro selection experiments were performed, with a total of 47 individual in 
vitro selection experiments. We used increasingly reactive sugar substrates and introduced 
modified DNA nucleotides with each new set of experiments to facilitate glycoside bond cleavage 
when the previous set failed to give activity (Table 3.1). All sugar substrates described below were 
conjugated to the 3′-amino DNA anchor oligonucleotide at the C6 carboxylate to form the amide 
derivative. The first set of in vitro selection experiments (arbitrarily designated as MT1–MZ1 and 
QD1 according to our laboratory’s systematic alphanumerical notation) started with methyl β-D-
lacturonide (MeLac conj.) as the sugar substrate and regular DNA nucleotides. MeLacA is used to 
denote the free uronic acid, and MeLac conj. is used to denote the amide derivative conjugated to 
the DNA for in vitro selection. The second set (SA1–SF1) used 4-nitrophenyl β-D-galacturonide 
(PNP-Gal conj.) as a more reactive sugar substrate. The third set (TM1–TW1) introduced modified 
nucleotides with the amino, hydroxyl, carboxyl, and imidazolyl functional groups (Figure 3.7). 
The fourth set (BK2–BT2) used CuAAC to install the boronic acid functional group as a potential 
sugar-binding moiety (Figure 3.8).10,11 The fifth set (ER2–EZ2) used 2,4-dinitrophenyl β-D-
galacturonide (DNP-Gal conj.) as the most reactive sugar substrate employed in our in vitro 
selection efforts. The sixth set (GE2–GM2) used both boronic acid modifications and carboxylate 
modifications simultaneously with DNP-Gal conj. 
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in vitro selection experiments sugar substrate modified nucleotides 
MT1–MZ1, QD1 MeLac conj. none 
SA1–SF1 PNP-Gal conj. none 
TM1–TW1 PNP-Gal conj. AmdU, HOdU, COOHdU, ImdU 
BK2–BT2 PNP-Gal conj. EdU + boronic acid 
ER2–EZ2 DNP-Gal conj. 
EdU + boronic acid 
EdU + carboxylic acid 
GE2–GM2 DNP-Gal conj. (EdU + boronic acid) & COOHdC 
 
Table 3.1. Summary of the key newly introduced variables in each set of in vitro selection 
experiments. See Section 3.4.3 for the other variables surveyed within each set (random region 
length, pH, and metal ion concentrations). 
 
Figure 3.7. Structures of modified dUs with protein-like functionality initially used for in vitro 
selection of amide bond hydrolysis deoxyribozymes (dR = deoxyribose).12 
 
Figure 3.8. Use of CuAAC to install boronic acid modifications on EdU to facilitate binding, and 
carboxylate modifications to facilitate catalysis. 
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3.2.1 Preparing Small-Molecule Sugar Substrates for In Vitro Selection 
 The small-molecule sugar substrates were oxidized at the C6 primary alcohol of the 
glycosyl group to form the respective uronic acid derivatives and conjugated to a 3′-amino DNA 
anchor oligonucleotide in a DMT-MM conjugation reaction.13 Selective oxidation at the primary 
alcohol in the presence of unprotected secondary alcohols was achieved by TEMPO oxidation 
(Figure 3.9). Three sugars were chosen as substrates for conjugation and in vitro selection: methyl 
β-D-lacturonide, 4-nitrophenyl β-D-galacturonide, and 2,4-dinitrophenyl β-D-galacturonide 
(Figure 3.10), each with a higher background hydrolysis rate than the previous one. 
 
Figure 3.9. The TEMPO oxidation is selective towards primary alcohols in the presence of 
secondary alcohols under basic conditions. 
 
Figure 3.10. Sugar substrates used in the in vitro selection of O-glycosidase deoxyribozymes. 
3.2.1.1 Methyl β-D-Lacturonide (MeLacA) 
A simple disaccharide was chosen as the initial substrate. Methyl β-D-lacturonide 
(compound 4), the uronic acid derivative of methyl β-D-lactoside, was chosen for synthetic 
considerations (Figure 3.11), and also because the posterior face of the galactosyl group could 
provide a potential hydrophobic binding site with the aromatic rings on DNA (Figure 3.12).14 Later 
experiments involving boronic acid modifications continued the use of galactosyl as the glycosyl 
group due to the presence of a 1,2-cis diol as a binding site for boronic acid.11 
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Figure 3.11. Synthetic route for methyl β-D-lacturonide (MeLacA). The TBDPS-protected 4′,6′-
benzylidene derivative of methyl β-D-lactoside (compound 1) was prepared as previously reported 
from methyl β-D-lactoside.3 
 
Figure 3.12. The posterior face of the galactosyl group can provide a potential site for hydrophobic 
interactions, as indicated by the CH-π interaction between the galactosyl group and W65 in the 
figure. Figure reprinted with permission from ref. 14. 
The carboxylate handle of the uronic acid provided a specific site for conjugation of the 
sugar to the 3′-amino DNA anchor oligonucleotide as an amide derivative and presentation to the 
initially random DNA pool. The covalent linkage is necessary to separate the catalytic sequences 
during the in vitro selection process. Sugar substrates used in subsequent in vitro selection 
experiments were similarly prepared. 
For the disaccharide substrate, the reducing end aldehyde was masked as part of the 
synthetic procedure. This allowed us to use the liberated aldehyde resulting from glycosidic bond 
cleavage as a target for the capture step during in vitro selection. 
3.2.1.2 4-Nitrophenyl β-D-Galacturonide (PNP-GalA) 
The lack of activity from in vitro selection experiments using the simple disaccharide 
substrate led us to pursue artificial sugar substrates with more reactive O-glycosidic bonds. PNP-
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Gal was chosen as a potential candidate. The pKa of the p-nitrophenolate leaving group is 7, which 
is significantly lower than the pKa of the disaccharide aglycone, which is 12.9,15 The intention was 
to aim for any O-glycoside cleavage activity. It is likely that if deoxyribozymes were to emerge 
from in vitro selection experiments using PNP-Gal conj., they would display little to no activity 
with natural disaccharide substrates. We intended to address such issues later on as they arose, for 
example by performing reselection experiments with MeLac. 
3.2.1.3 2,4-Dinitrophenyl β-D-Galacturonide (DNP-GalA) 
2,4-Dinitrophenyl β-D-galacturonide was the most reactive O-glycoside used in our in vitro 
selection experiments. Extensive background assays were performed using various pH values and 
divalent metal ion concentrations for DNP-Gal conj. to identify suitable conditions for in vitro 
selection (Figure 3.13). According to previous esterase studies and parallel acyltransferase studies 
in the Silverman lab, we determined that aiming for a background hydrolysis (degradation) rate of 
the substrate of 1%−5% would be suitable.16 A background rate too high would leave little room 
for enzyme rate enhancement, while a background rate too low for difficult reactions might impose 
too high of a rate enhancement threshold for deoxyribozymes to emerge during the in vitro 
selection process. 
 
Figure 3.13. Representative analysis of the stability of DNP-Gal conj. using various buffers and 
divalent metal ion concentrations (Table 3.2). All lanes were incubated at 37 °C for 2 h. 
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lane buffer 
divalent metal ion concentrations 
[Mg2+] [Mn2+] [Zn2+] 
1 
MES, pH 6.0 
20 mM 10 mM 1 mM 
2 10 mM 5 mM 1 mM 
3 10 mM 5 mM  
4 10 mM  1 mM 
5 
HEPES, pH 7.5 
20 mM 10 mM 1 mM 
6 10 mM 5 mM 1 mM 
7 10 mM 5 mM  
8 10 mM  1 mM 
9 
CHES, pH 9.0 
20 mM   
10 10 mM   
11 5 mM   
12 0 mM   
 
Table 3.2. Incubation conditions for background hydrolysis assay of DNP-Gal conj. 
% 𝑜𝑏𝑠𝑒𝑟𝑣𝑒𝑑 𝑐𝑎𝑝𝑡𝑢𝑟𝑒 =  42% ×
𝐺𝑎𝑙
𝐺𝑎𝑙 + 𝐷𝑁𝑃𝐺𝑎𝑙
+ 1.6% ×
𝐷𝑁𝑃𝐺𝑎𝑙
𝐺𝑎𝑙 + 𝐷𝑁𝑃𝐺𝑎𝑙
 
% 𝑏𝑎𝑐𝑘𝑔𝑟𝑜𝑢𝑛𝑑 ℎ𝑦𝑑𝑟𝑜𝑙𝑦𝑠𝑖𝑠 =
𝐺𝑎𝑙
𝐺𝑎𝑙 + 𝐷𝑁𝑃𝐺𝑎𝑙
=
% 𝑜𝑏𝑠𝑒𝑟𝑣𝑒𝑑 𝑐𝑎𝑝𝑡𝑢𝑟𝑒 − 1.6
42 − 1.6
 
 
Equation 3.1. Calculation of % background hydrolysis (degradation) of DNP-Gal conj. under the 
various incubation conditions, correcting for hydrazide capture yield. 
2,4-Dinitrophenyl β-D-galactoside was prepared from galactose in one step using 1-fluoro-
2,4-dinitrobenzene (Figure 3.14).17 The subsequent oxidation to DNP-GalA was more difficult due 
to two competing factors at the optimal reaction pH (Figure 3.15).18 The TEMPO oxidation 
required a high pH, which accelerated the base-catalyzed deglycosylation of the galactoside.19 The 
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reaction was performed at pH 9.0, which was effective at inhibiting base-catalyzed deglycosylation 
but led to significantly lower yield of the TEMPO oxidation. Nevertheless, the synthetic route was 
useful since the starting material galactose can easily be used on a large scale. 
 
Figure 3.14. Synthetic route for DNP-GalA from galactose. 
 
 
Figure 3.15. Competing factors for optimal pH in the TEMPO oxidation of DNP-Gal to form 
DNP-GalA. The left graph shows the rate of TEMPO oxidation as a function of pH. The right 
graph shows the rate of base-catalyzed deglycosylation of the DNP group as a function of pH. A 
pH value of 9.0 was chosen as a compromise between the two conflicting factors. Figures reprinted 
with permission from ref. 18. 
3.2.2 Hydrazide Capture Step 
 The loss of the aglycone is insufficient to differentiate between catalytic sequences and 
noncatalytic sequences by PAGE. Taking advantage of aldehyde formation resulting from 
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glycosidic bond cleavage, hydrazide capture was used to add an oligonucleotide to the sugar 
substrates linked to catalytic sequences for gel shift separation. Compared to previous efforts with 
embedded sugar substrates that isolated sequences based on a loss of mass (Figure 3.1), the 
hydrazide capture step separates sequences based on an increase of mass and has the additional 
benefit of avoiding various side reactions that lead to strand scission. 
The 5′-hydrazide oligo was prepared by solid-phase synthesis and PAGE purification. 
Hydrazide capture was performed by reaction of the hydrazide oligo with the sugar aldehyde in a 
splint-assisted reaction. Glucuronic acid conjugated to the 3′-amino DNA anchor oligonucleotide 
was used as an external capture standard and also served as a location marker on PAGE. The 
capture reaction with the standard glucose substrate plateaus at 30-35% under the optimized 
conditions (Figure 3.16). 
 
Figure 3.16. Time dependence of the hydrazide capture reaction under optimized conditions. The 
hydrazide capture step was performed for 8-12 h during the in vitro selection rounds. 
Gel-based in vitro selection achieves separation and enrichment of the target catalytic 
sequences by size. Sequences from the population that do not possess the desired catalytic activity 
can still migrate to the gel excision area in multiple ways (Figure 3.17). They can be categorized 
based on whether the DNA sequences survive in a reproducible manner, and as reaction-based 
artifacts or gel separation-based artifacts (Table 3.3). 
50 
 
 
   
Figure 3.17. Illustration of carryover of DNA sequences without the desired catalytic activity 
(depicted in gray) during the selection step. The selection step leads to enrichment of catalytic 
sequences (depicted in red), but enrichment is not complete as discussed in the main text. The 
enrichment factor can be conceptualized as (shaded red area/shaded gray area)/(area below red 
curve/area below gray curve). The horizontal red lines indicate the gel excision area, and the 
shaded gray area represents undesired sequences that are carried over. The various processes by 
which undesired sequences can be carried over is summarized in Table 3.3. In addition, the 
hydrazide capture yield is 30-35% after optimization, as shown by the capture standard on the 
right, so not all the catalytic sequences end up in the excision area, further reducing the enrichment 
factor. The areas under the distribution curves and distances between the peaks and bands are not 
to scale. 
 reproducible nonreproducible 
reaction-based artifact catalysis of nontargeted reaction background reaction of substrate 
gel separation-based artifact aberrantly migrating sequences 
physical entanglement in gel; 
band overlap at tail end 
 
Table 3.3. Summary of the various processes by which sequences without desired catalytic activity 
can nevertheless end up in the excision area for catalytic sequences. 
For the in vitro selection of O-glycosidase deoxyribozymes, reproducible reaction-based 
artifacts involve DNA sequences that produce a capturable aldehyde despite not catalyzing 
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cleavage of the O-glycoside bond. The aldehyde can originate from DNA sequences that catalyze 
a side reaction such as depurination or depyrimidination along the DNA anchor oligonucleotide, 
which leads to undesired sequences that reproducibly comigrate on PAGE with the desired 
catalytic sequences on PAGE. Nonreproducible reaction-based artifacts result from minor 
background hydrolysis of the O-glycoside substrate. Such sequences do not reproducibly 
comigrate and will likely be eliminated in subsequent in vitro selection rounds. 
Reproducible gel separation-based artifacts involve DNA sequences that do not migrate 
strictly based on size. Such sequences are usually aberrantly folded and can end up in the excision 
zone despite having less mass than required. Nonreproducible gel separation-based artifacts result 
from DNA sequences being subject to physical entanglement and diffusion as they run though the 
gel. Physical entanglement leads to distortion of the gel bands and a skewed tail. Diffusion leads 
to widening of the gel bands. Either may cause minor overlap at the tail end. 
DNA sequences without the desired catalytic activity that end up in the excision area in a 
nonreproducible manner are not a long-term issue, since they are not favored to survive in 
subsequent in vitro selection rounds. In contrast, undesired sequences that reproducibly comigrate 
with the catalytic sequences must be addressed, such as by installing a disulfide linkage in the 
substrate and adding a post-capture DTT treatment step. 
3.2.3 DTT Treatment Step 
In order to eliminate the undesired sequences that reproducibly comigrate with the catalytic 
sequences, the hydrazide capture product was treated by DTT and PAGE-purified a second time 
(Figure 3.18). DTT cleaves the disulfide bond embedded within the linker between the sugar 
substrate and the DNA anchor oligonucleotide. This causes a significant loss of mass only if the 
hydrazide capture reaction correctly happened at the aldehyde produced by cleaving the sugar 
substrate. 
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Figure 3.18. Illustration of carryover of undesired sequences that catalyze nontargeted reactions 
such as N-deglycosylation. N-deglycosylation along the DNA anchor oligonucleotide also leads 
to the formation of an aldehyde that can be captured by the hydrazide oligo. The products of 
O-deglycosylation (red) and N-deglycosylation (orange) can be separated by DTT treatment and 
a second gel purification step. This also eliminates any sequences that aberrantly migrate to the 
excision area (not shown). The areas under the distribution curves and distances between the peaks 
and bands are not to scale. 
3.2.4 In Vitro Selection with Modified Nucleotides 
The lack of O-glycosidase activity with in vitro selection experiments using natural 
nucleotides led us to pursue the use of modified nucleotides. Overall, five functional group 
modifications were tested: amino, hydroxyl, carboxyl, imidazolyl, and boronic acid. In addition, a 
combination of the carboxyl and boronic acid modifications was also tested, as these two 
modifications were deemed the most likely to be critical for glycosidase activity (Section 
2.2.3.1).11,20 
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3.2.5 Other In Vitro Selection Variables 
pH is a common variable for in vitro selection experiments. The optimal pH for most 
protein glycosidases lies in the pH 3-8 range, which encompasses the pKa of side-chain 
carboxylates, due to the reliance of protein glycosidases on the dicarboxylate catalytic pathway.20 
For in vitro selection experiments where the carboxylate modification was used, we prioritized pH 
6.0 as one of the conditions. In addition, at lower pH values a higher percentage of the aglycone is 
protonated prior to glycosidic bond cleavage, which makes it a better leaving group and facilitates 
the reaction. 
Random region length is also a consideration. There are two competing factors when 
increasing random region length. The range of complicated structures accessible to the DNA 
sequences increases as sequence length is increased. The sequence space also increases 
exponentially, which reduces the fraction of sequence space sampled. Most of the in vitro selection 
experiments were performed with an N40 random region, which contains 1024 possible sequences, 
1014 of which are sampled, representing a fraction of 10−10. Previous research has demonstrated 
that the optimal random region length for in vitro selection can vary based on the targeted 
reaction.21 
3.2.6 Outcome of In Vitro Selection Experiments 
 None of the in vitro selection experiments gave activity after 14 rounds and were 
discontinued. Because the uncatalyzed rate of O-glycosidic bond cleavage is higher than the 
uncatalyzed rates of some reactions for which deoxyribozymes have been identified, it seems 
likely that DNA is simply unsuited for interaction with the sugar substrates, despite being provided 
with various additional functional groups, including boronic acid which has a strong affinity for 
diols. The poor ability of DNA to interact with carbohydrates has been documented in DNA 
aptamer studies for glycoproteins, although the installation of boronic acid moieties has led to 
some success there.14 Overall, unsuccessful in vitro selection experiments do not provide a wealth 
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of data. The only certain conclusion we can draw is that the in vitro selection experiments did not 
work using the aforementioned specific experimental setups. 
3.3 Summary and Outlook 
The in vitro selection of O-glycosidase deoxyribozymes was unsuccessful. We have 
approached the issue from a functional group perspective, providing the DNA sequences access to 
boronic acid and carboxylate functional groups, among others, to facilitate both binding and 
catalysis. We have also approached the issue from a substrate perspective, providing the DNA 
sequences with PNP-Gal conj. and DNP-Gal conj. as substrates, which have a lower energetic 
barrier for hydrolysis compared to MeLac conj. Despite all of these approaches, the in vitro 
selection experiments have been unsuccessful, and the negative outcomes do not provide any 
strong conclusions. 
Regarding future in vitro selection efforts, as we have observed in ongoing acyltransferase 
deoxyribozymes studies (Tianjiong Yao, unpublished results), for difficult reactions it may be 
desirable to swing the pendulum far in the other direction and aim for reactivity first, regardless of 
how far removed the substrates may be from natural products. After the reactivity at the far end of 
the spectrum is established, the substrate identity and in vitro selection conditions can be adjusted 
accordingly to lower the background reactivity of the substrate and provide room for enzyme rate 
enhancement. This is a new paradigm compared to our previous methods of inching up substrate 
reactivity and may prove to be a more rapid approach to identify deoxyribozymes or reach the 
conclusion that an endeavor is empirically infeasible. 
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3.4 Materials and Methods 
3.4.1 Substrate Preparation Procedures 
Oligonucleotides and reagents. DNA oligonucleotides were purchased from Integrated 
DNA Technologies (Coralville, IA) or prepared by solid-phase synthesis on an ABI 394 instrument 
using reagents purchased from Glen Research. All oligonucleotides were purified by 7 M urea 
denaturing PAGE with 1× TBE (89 mM each of Tris and boric acid, 2 mM EDTA, pH 8.3), 
extracted from polyacrylamide with TEN buffer (10 mM Tris, pH 8.0, 1 mM EDTA, 300 mM 
NaCl) and precipitated with ethanol prior to use, as described previously.22,23 
Preparation of 5′-hydrazide capture oligonucleotide. The final coupling of the solid-phase 
synthesis was done with a 5′-carboxy-modifier C10 phosphoramidite. The oligonucleotide was 
deprotected and cleaved from the CPG beads by manual treatment with 12.5% hydrazine in 1:1 
water/ethanol for 17 h in place of ammonia deprotection and purified by 20% PAGE. 
Preparation of 3′-amino DNA anchor oligonucleotide with an embedded disulfide linker. 
Each DNA oligonucleotide was synthesized on a thiol linker. After deprotection and purification 
by 20% PAGE, the disulfide bond was cleaved by treatment with 50 mM DTT in 100 mM HEPES, 
pH 7.5 at 37 °C for 2 h. The free thiol was activated by treatment with 100 mM Aldrithiol in 100 
mM TEAA, pH 7.0 at 37 °C for 2 h. The activated thiol oligonucleotides were functionalized with 
an amine by treatment with 200 mM cysteamine in 100 mM TEAA, pH 7.0 at 37 °C for 6 h. 
Ethanol precipitation was performed prior to each step to remove the reagents used in the previous 
step. 
Conjugation of sugar substrate and 3′-amino DNA anchor oligonucleotide. The DNA 
anchor oligonucleotide was incubated overnight at 37 °C with 1 mM of the uronic acid derivative 
(MeLacA, PNP-GalA, or DNP-GalA) and 450 mM DMT-MM in 50 mM MOPS, pH 7.0. The 
product was purified by 20% PAGE. 
2′-Deoxynucleotide 5′-triphosphates. AmdU 5′-triphosphate (AmdUTP) was purchased from 
TriLink BioTechnologies (cat. no. N-0249). HOdU 5′-triphosphate (HOdUTP) was purchased from 
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TriLink BioTechnologies (cat. no. N-0259). COOHdU 5′-triphosphate (COOHdUTP) and ImdU 5′-
triphosphate (ImdUTP) were synthesized as described previously.9 5-Ethynyl-dU 5′-triphosphate 
(EdUTP) was purchased from Baseclick GmbH (cat. no. BCT-08-L). 
2′-Deoxynucleoside 3′-phosphoramidites. AmdU phosphoramidite was purchased from 
Berry & Associates (cat. no. BA0311). COOHdU phosphoramidite was purchased from Glen 
Research (cat. no. 10-1035). HOdU phosphoramidite was purchased from Glen Research (cat. no. 
10-1093). 
3.4.2 Organic Synthesis Procedures 
 Reagents were commercial grade and used without purification unless otherwise indicated. 
Thin-layer chromatography (TLC) was performed on silica gel plates precoated with fluorescent 
indicator. Visualization was done by UV light (254 nm) or anisaldehyde staining. NMR spectra 
were recorded on a Varian VXR 500 at the UIUC School of Chemical Sciences NMR Laboratory. 
Chemical shifts in parts per million (δ) are reported downfield from TMS (0 ppm) and referenced 
to the residual proton signals for D2O (4.70 ppm), CD3OD (3.31 ppm), or DMSO-d6 (2.50 ppm). 
Apparent multiplicities of 1H NMR peaks are reported as s (singlet), d (doublet), t (triplet), q 
(quartet), or m (multiplet and overlapping spin systems), along with values for apparent coupling 
constants (J, Hz). Low-resolution ESI mass spectrometry data were obtained on a Waters Quattro 
at the UIUC School of Chemical Sciences Mass Spectrometry Laboratory. 
Synthesis of methyl β-D-lacturonide (4) from 1. To a solution of TBDPS-protected 4′,6′-
benzylidene derivative of methyl β-D-lactoside (1, 480 mg, 0.7 mmol) in 5 mL of methanol was 
added 10% palladium hydroxide on carbon (200 mg) and acetic acid (100 μL, 1.75 mmol), and the 
solution was sparged vigorously with hydrogen gas for 6 h. The reaction mixture was filtered 
through a Celite pad, the Celite pad was rinsed twice with methanol, the solutions were combined, 
and the solvent was evaporated to yield 2 as a white solid (405 mg, 84%). 
TLC: Rf = 0.10 [10% CH3OH in CHCl3]. 
ESI-MS: m/z calcd. for C29H42O11Si [M+Na]+ 617.2; found 617.4. 
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To a solution of 2 (200 mg, 0.34 mmol) in 5 mL of dichloromethane was added TEMPO 
(5 mg, 0.03 mmol), sodium bromide (14 mg, 0.13 mmol), and 10 mL of saturated sodium 
bicarbonate buffer, pH 10.0. A solution of 10% sodium hypochlorite (0.5 mL) was added dropwise, 
and the biphasic solution was stirred vigorously on ice for 4 h. The pH was adjusted to 8.0 by the 
addition of 5−6 mL of 0.1 M hydrochloric acid and monitored by pH paper. 10 mL of saturated 
aqueous NaCl was added, and the product precipitated as the sodium salt. The reaction mixture 
was filtered to yield the sodium salt of 3 as a white solid (110 mg, 54%). 
TLC: Rf = 0.08 [20% CH3OH in CHCl3 with 0.5% (v/v) AcOH]. 
1H NMR: (500 MHz, CD3OD) δ 7.78 (m, 3H), 7.40 (m, 5H), 4.70 (d, J = 4.8 Hz, 1H), 4.35 (m, 
1H), 4.20 (d, J = 4.8 Hz, 1H), 4.15 (m, 1H), 4.01 (t, J = 5.5 Hz, 1H), 3.95 (d, J = 5.5 Hz, 1H), 3.85 
(s, 1H), 3.54 (m, 6H), 3.41 (m, 1H), 1.03 (s, 9H) ppm. 
ESI-MS: m/z calcd. for C29H40O12SiNa [M−Na]− 607.2; found 607.4. 
 To a solution of the sodium salt of 3 (110 mg, 0.18 mmol) in 2 mL of methanol was added 
tetrabutylammonium fluoride (1.35 mL, 4.7 mmol), and the solution was heated at reflux at 60 °C 
for 3 h. Tetrabutylammonium was removed by ion exchange with H+ by the addition of Dowex 
resin. The reaction mixture was filtered, and the solvent was evaporated to yield 4 as a white solid 
(5.9 mg, 9%). 
ESI-MS: m/z calcd. for C13H22O12 [M−H]− 369.1; found 369.1. 
 Synthesis of 4-nitrophenyl β-D-galacturonide from 4-nitrophenyl β-D-galactoside.24 
4-Nitrophenyl β-D-galactoside (106 mg, 0.35 mmol) was dissolved in 5.3 mL of 100 mM 
NaHCO3/Na2CO3 buffer, pH 10.7. To this solution was added TEMPO (0.9 mg, 0.006 mmol) and 
sodium bromide (8 mg, 0.078 mmol), and the solution was cooled to 0 °C in an ice-water bath. A 
solution of 5% aqueous sodium hypochlorite (1.2 mL) was added dropwise, and the solution was 
allowed to return to room temperature with stirring. After 3 h, another 0.9 mg of TEMPO and 1.2 
mL of 5% aqueous sodium hypochlorite were added, and the solution was stirred at room 
temperature for 48 h. The reaction was quenched by the addition of 4.5 mL of methanol, and the 
solution was stirred at room temperature for 1 h. The solution was concentrated on a rotary 
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evaporator to approximately 2 mL and purified by HPLC [Shimadzu Prominence instrument; 
Phenomenex Gemini-NX C18 column, 5 μm, 10 × 250 mm; gradient of 21% solvent A (20 mM 
triethylammonium acetate in 50% acetonitrile/50% water, pH 7.0) and 79% solvent B (20 mM 
triethylammonium acetate in water, pH 7.0) at 0 min to 32% solvent A and 68% solvent B at 30 
min with flow rate of 3.5 mL/min]. The product was collected and lyophilized to give a yellow 
solid (15 mg, 14%). 
ESI-MS: m/z calcd. for C12H13NO9 [M+Na−2H]− 336.0 found 335.8. 
1H NMR: (500 MHz, CD3OD) δ 8.19 (d, J = 6.2 Hz, 2H), 7.18 (d, J = 6.2 Hz, 2H), 5.13 (d, J = 4.6 
Hz, 1H), 3.95 (m, 1H), 3.87 (m, 1H), 3.79 (m, 1H), 3.72 (m, 3H) ppm. 
 Synthesis of 2,4-dinitrophenyl β-D-galactoside from galactose. To a solution of galactose 
(500 mg, 2.78 mmol) in 5 mL of water was added sodium bicarbonate (500 mg, 5.95 mmol) and 
1-fluoro-2,4-dinitrobenzene (1 g, 5.56 mmol) in 5 mL of ethanol, and the solution was stirred in 
dark for 24 h. The solution was concentrated on a rotary evaporator and purified by silica gel 
column chromatography, eluting with 10% methanol in dichloromethane. The product was 
obtained a yellow solid (70 mg, 7.3%). 
TLC: Rf = 0.48 [25% methanol in dichloromethane]. 
ESI-MS: m/z calcd. for C12H14N2O10 [M+Na]+ 369.0; found 369.1. 
Synthesis of 2,4-dinitrophenyl β-D-galacturonide from 2,4-dinitrophenyl β-D-galactoside. 
2,4-Dinitrophenyl β-D-galactoside (70 mg, 0.20 mmol) was dissolved in 3 mL of 100 mM 
NaHCO3/Na2CO3 buffer, pH 9.0. To this solution was added TEMPO (0.5 mg, 0.003 mmol) and 
sodium bromide (5 mg, 0.049 mmol), and the solution was cooled to 0 °C in an ice-water bath. A 
solution of 5% aqueous sodium hypochlorite (1.0 mL) was added dropwise, and the solution was 
stirred at 0 °C for 24 h. The reaction was quenched by the addition of 2.5 mL of methanol, and the 
solution was stirred at 0 °C for 1 h. The solution was concentrated on a rotary evaporator and 
purified by HPLC [Shimadzu Prominence instrument; Phenomenex Gemini-NX C18 column, 5 
μm, 10 × 250 mm; gradient of 3% solvent A (20 mM triethylammonium acetate in 50% 
acetonitrile/50% water, pH 7.0) and 97% solvent B (20 mM triethylammonium acetate in water, 
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pH 7.0) at 0 min to 20% solvent A and 80% solvent B at 30 min with flow rate of 3.5 mL/min]. 
The product was collected and lyophilized to give a yellow solid (10 mg, 13%). 
ESI-MS: m/z calcd. for C12H12N2O11 [M+Na−2H]− 381.0; found 381.2. 
1H NMR: (500 MHz, CD3OD) δ 8.76 (s, 1H), 8.40 (d, J = 6.4 Hz, 1H), 7.31 (d, J = 6.4 Hz, 1H), 
5.33 (d, J = 4.7 Hz, 1H), 4.02 (m, 1H), 3.94 (m, 1H), 3.83 (m, 1H), 3.74 (m, 3H) ppm. 
3.4.3 In Vitro Selection Variables 
 
exp. conj. substrate 
modified 
nucleotides 
random region 
length pH metal ion concentrations 
MT1 MeLac none 30 7.5 40 mM Mg2+, 20 mM Mn2+, 1 mM Zn2+ 
MV1 MeLac none 40 7.5 40 mM Mg2+, 20 mM Mn2+, 1 mM Zn2+ 
MW1 MeLac none 40 9.0 40 mM Mg2+ 
MX1 MeLac none 50 7.5 40 mM Mg2+, 20 mM Mn2+, 1 mM Zn2+ 
MY1 
MeLac 
(HEG) 
none 40 7.5 40 mM Mg2+, 20 mM Mn2+, 1 mM Zn2+ 
MZ1 
MeLac 
(HEG) 
none 40 9.0 40 mM Mg2+ 
QD1 MeLac none 80 7.5 40 mM Mg2+, 20 mM Mn2+, 1 mM Zn2+ 
SA1 PNP-Gal none 40 6.0 40 mM Mg2+, 20 mM Mn2+, 1 mM Zn2+ 
SB1 PNP-Gal none 40 7.5 40 mM Mg2+, 20 mM Mn2+, 1 mM Zn2+ 
SC1 PNP-Gal none 60 6.0 40 mM Mg2+, 20 mM Mn2+, 1 mM Zn2+ 
SD1 PNP-Gal none 80 6.0 40 mM Mg2+, 20 mM Mn2+, 1 mM Zn2+ 
SE1 PNP-Gal none 40 6.0 40 mM Mg2+, 20 mM Mn2+, 1 mM Zn2+ 
SF1 
PNP-Gal 
(HEG) 
none 40 7.5 40 mM Mg2+, 20 mM Mn2+, 1 mM Zn2+ 
TM1 PNP-Gal AmdU 40 7.5 40 mM Mg2+, 20 mM Mn2+, 1 mM Zn2+ 
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TN1 PNP-Gal ImdU 40 7.5 40 mM Mg2+, 20 mM Mn2+, 1 mM Zn2+ 
TP1 PNP-Gal COOHdU 40 7.5 40 mM Mg2+, 20 mM Mn2+, 1 mM Zn2+ 
TQ1 PNP-Gal COOHdU 40 6.0 40 mM Mg2+, 20 mM Mn2+, 1 mM Zn2+ 
TR1 PNP-Gal HOdU 40 7.5 40 mM Mg2+, 20 mM Mn2+, 1 mM Zn2+ 
TS1 MeLac AmdU 40 7.5 40 mM Mg2+, 20 mM Mn2+, 1 mM Zn2+ 
TT1 MeLac ImdU 40 7.5 40 mM Mg2+, 20 mM Mn2+, 1 mM Zn2+ 
TV1 MeLac COOHdU 40 7.5 40 mM Mg2+, 20 mM Mn2+, 1 mM Zn2+ 
TW1 MeLac COOHdU 40 6.0 40 mM Mg2+, 20 mM Mn2+, 1 mM Zn2+ 
BK2 PNP-Gal EdU (b.a.) 40 6.0 40 mM Mg2+, 20 mM Mn2+, 1 mM Zn2+ 
BL2 PNP-Gal EdU (b.a.) 40 7.5 40 mM Mg2+, 20 mM Mn2+, 1 mM Zn2+ 
BM2 PNP-Gal EdU (b.a.) 40 9.0 40 mM Mg2+ 
BN2 MeLac EdU (b.a.) 40 6.0 40 mM Mg2+, 20 mM Mn2+, 1 mM Zn2+ 
BP2 MeLac EdU (b.a.) 40 7.5 40 mM Mg2+, 20 mM Mn2+, 1 mM Zn2+ 
BQ2 MeLac EdU (b.a.) 40 9.0 40 mM Mg2+ 
BR2 PNP-Gal EdU (b.a.) 80 6.0 40 mM Mg2+, 20 mM Mn2+, 1 mM Zn2+ 
BS2 PNP-Gal EdU (b.a.) 80 7.5 40 mM Mg2+, 20 mM Mn2+, 1 mM Zn2+ 
BT2 PNP-Gal EdU (b.a.) 80 9.0 40 mM Mg2+ 
ER2 DNP-Gal none 40 6.0 10 mM Mg2+, 5 mM Mn2+, 1 mM Zn2+ 
ES2 DNP-Gal EdU (b.a.) 40 6.0 10 mM Mg2+, 5 mM Mn2+, 1 mM Zn2+ 
ET2 DNP-Gal EdU (c.a.) 40 6.0 10 mM Mg2+, 5 mM Mn2+, 1 mM Zn2+ 
EV2 DNP-Gal none 40 7.5 10 mM Mg2+, 5 mM Mn2+, 1 mM Zn2+ 
EW2 DNP-Gal EdU (b.a.) 40 7.5 10 mM Mg2+, 5 mM Mn2+, 1 mM Zn2+ 
EX2 DNP-Gal EdU (c.a.) 40 7.5 10 mM Mg2+, 5 mM Mn2+, 1 mM Zn2+ 
EY2 DNP-Gal none 40 9.0 20 mM Mg2+ 
EZ2 DNP-Gal EdU (b.a.) 40 9.0 20 mM Mg2+ 
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GE2 DNP-Gal EdU (b.a.), COOHdC 40 6.0 10 mM Mg2+, 5 mM Mn2+, 1 mM Zn2+ 
GF2 DNP-Gal EdU (b.a.), COOHdC 80 6.0 10 mM Mg2+, 5 mM Mn2+, 1 mM Zn2+ 
GG2 PNP-Gal EdU (b.a.), COOHdC 40 6.0 40 mM Mg2+, 20 mM Mn2+, 1 mM Zn2+ 
GH2 PNP-Gal EdU (b.a.), COOHdC 80 6.0 40 mM Mg2+, 20 mM Mn2+, 1 mM Zn2+ 
GJ2 DNP-Gal EdU (b.a.), COOHdC 40 7.5 10 mM Mg2+, 5 mM Mn2+, 1 mM Zn2+ 
GK2 DNP-Gal EdU (b.a.), COOHdC 80 7.5 10 mM Mg2+, 5 mM Mn2+, 1 mM Zn2+ 
GL2 DNP-Gal EdU (b.a.), COOHdC 40 9.0 20 mM Mg2+ 
GM2 DNP-Gal EdU (b.a.), COOHdC 80 9.0 20 mM Mg2+ 
 
Table 3.4. Summary of all variables surveyed across the in vitro selection experiments of 
O-glycosidase deoxyribozymes. b.a. = boronic acid, c.a. = carboxylic acid. Substrates were 
conjugated to the C3 amine or HEG amine at the end of a DNA anchor oligonucleotide. 
3.4.4 In Vitro Selection Procedures 
Procedure for primer extension with modified 2′-deoxyuridine 5′-triphosphates to generate 
initially random DNA pools for in vitro selection. A 50 μL sample was prepared containing 250 
pmol of the synthesized reverse complement template, 500 pmol of forward primer, 15 nmol each 
of dATP, dCTP, dGTP, and  modified dUTP, 5 μL of 10× KOD XL polymerase buffer, and 1 μL 
of KOD XL polymerase (prepared by Silverman lab member Shannon Walsh). Primer extension 
was performed by cycling 4 times in a PCR thermocycler according to the following program: 
94 °C for 2 min, 4× (94 °C for 2 min, 47 °C for 2 min, 72 °C for 60 min), 72 °C for 60 min. The 
product was purified by 8% PAGE. 
Procedure for ligation step in round 1. A 26 μL sample containing 500 pmol of DNA pool, 
600 pmol of DNA splint, and 750 pmol of 5′-phosphorylated DNA-anchored peptide substrate was 
annealed in 5 mM Tris, pH 7.5, 15 mM NaCl, and 0.1 mM EDTA by heating at 95 °C for 3 min 
and cooling on ice for 5 min. To this solution was added 3 μL of 10× T4 DNA ligase buffer without 
DTT (400 mM Tris, pH 7.8, 100 mM MgCl2, and 5 mM ATP) and 1 μL of 5 U/μL T4 DNA ligase 
(Thermo Fisher). The sample was incubated at 37 °C for 12 h and purified by 8% PAGE. 
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Procedure for ligation step in subsequent rounds. A 17 μL sample containing the 
PCR-amplified DNA pool (~5–10 pmol), 25 pmol of DNA splint, and 50 pmol of 
5′-phosphorylated DNA-anchored peptide substrate was annealed in 5 mM Tris, pH 7.5, 15 mM 
NaCl, and 0.1 mM EDTA by heating at 95 °C for 3 min and cooling on ice for 5 min. To this 
solution was added 2 μL of 10× T4 DNA ligase buffer without DTT (400 mM Tris, pH 7.8, 100 
mM MgCl2, and 5 mM ATP) and 1 μL of 1 U/μL T4 DNA ligase (Thermo Fisher). The sample 
was incubated at 37 °C for 12 h and purified by 8% PAGE. 
Procedure for selection step in round 1. Each in vitro selection experiment was initiated 
with 200 pmol of the ligated pool. A 16 μL sample containing 200 pmol of ligated pool was 
annealed in 5 mM HEPES, pH 7.5 (or MES for pH 6.0, CHES for pH 9.0), 15 mM NaCl, and 0.1 
mM EDTA by heating at 95 °C for 3 min and cooling on ice for 5 min. The selection step was 
initiated by bringing the sample to 40 μL total volume containing 70 mM HEPES, pH 7.5 (or the 
corresponding buffer for the other pH values), 40 mM MgCl2, 20 mM MnCl2, 1 mM ZnCl2, and 
150 mM NaCl. The Mg2+ was added from a 10× stock solution containing 400 mM MgCl2. The 
Mn2+ was added from a 10× stock solution containing 200 mM MnCl2. The Zn2+ was added from 
a 10× stock solution containing 10 mM ZnCl2, 20 mM HNO3, and 200 mM HEPES at pH 7.5; this 
stock solution was freshly prepared from a 100× stock of 100 mM ZnCl2 in 200 mM HNO3. Mn2+ 
and Zn2+ were omitted for in vitro selection experiments at pH 9.0 due to precipitation of the metal 
hydroxides at higher pH values. The metal ion stocks were added last to the final sample. The 
sample was incubated at 37 °C for 12-14 h and separated by 8% PAGE. 
Procedure for selection step in subsequent rounds. An 8 μL sample containing the ligated 
pool was annealed in 5 mM HEPES, pH 7.5 (or the corresponding buffer for the other pH values), 
15 mM NaCl, and 0.1 mM EDTA by heating at 95 °C for 3 min and cooling on ice for 5 min. The 
selection step was initiated by bringing the sample to 20 μL total volume containing 70 mM 
HEPES, pH 7.5 (or the corresponding buffer for the other pH values), 40 mM MgCl2, 20 mM 
MnCl2, 1 mM ZnCl2, and 150 mM NaCl. Mn2+ and Zn2+ were omitted for in vitro selection 
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experiments at pH 9.0 due to precipitation of the metal hydroxides at higher pH values. The sample 
was incubated at 37 °C for 12-14 h and separated by 8% PAGE. 
Procedure for hydrazide capture step in each round. The sample from the selection step 
was quenched with 5 μL of 0.5 M EDTA and precipitated with ethanol. The pellet was dissolved 
in water and brought to 20 µL total volume containing 100 mM sodium acetate, pH 4.5, 100 mM 
sodium cyanoborohydride, 10 mM 5-methoxyanthranilic acid (5-MA), 15 pmol splint 
oligonucleotide, and 30 pmol hydrazide oligonucleotide. The sample was incubated at 37 °C for 
8-12 h and separated by 8% PAGE. A DNA anchor oligonucleotide conjugated to glucose was 
captured alongside as an external control, with a standard capture yield of 30-35%. The capture 
product of glucose was used as a location marker on PAGE. 
Procedure for post-capture step DTT reduction. The capture product was excised from 
PAGE, extracted with TEN, and precipitated with ethanol. The pellet was dissolved in water and 
brought to 20 μL total volume containing 100 mM HEPES, pH 7.5, and 50 mM DTT. The sample 
was incubated at 37 °C for 2 h and separated by 8% PAGE. 
Procedure for PCR for in vitro selection with natural nucleotides. In each in vitro selection 
round, two PCR reactions were performed, a 10-cycle PCR followed by a 30-cycle PCR. For the 
10-cycle PCR, a 100 μL sample was prepared containing the PAGE-purified DTT-treatment 
product, 200 pmol of forward primer, 50 pmol of reverse primer, 20 nmol of each dNTP, 10 μL of 
10× Taq polymerase buffer, and 2 μL of Taq polymerase. The sample was cycled 10 times 
according to the following PCR program: 94 °C for 2 min, 10× (94 °C for 30 s, 47 °C for 30 s, 
72 °C for 30 s), 72 °C for 5 min. Taq polymerase was removed by phenol/chloroform extraction. 
For the 30-cycle PCR, a 50 μL sample was prepared containing 1 μL of the 10-cycle PCR product, 
100 pmol of forward primer, 25 pmol of reverse primer, 10 nmol of each dNTP, 10 μCi of α-32P-
dCTP (800 Ci/mmol), 5 μL of 10× Taq polymerase buffer, and 1 μL of Taq polymerase. This 
sample was cycled 30 times according to the following PCR program: 94 °C for 2 min, 30× (94 °C 
for 30 s, 47 °C for 30 s, 72 °C for 30 s), 72 °C for 5 min. The sample was separated by 8% PAGE. 
The forward and reverse single-stranded PCR products were separable because formation of the 
64 
 
reverse product was initiated using the reverse primer, which contains an oligonucleotide tail 
separated by a nonamplifiable spacer that stops Taq polymerase. 
Procedure for PCR for in vitro selection with modified nucleotides. In each in vitro 
selection round, two PCR reactions were performed, a 10-cycle PCR followed by a 30-cycle PCR. 
For the 10-cycle PCR, a 100 μL sample was prepared containing the PAGE-purified DTT-
treatment product, 50 pmol of forward primer, 200 pmol of reverse primer, 20 nmol of each dNTP, 
10 μL of 10× KOD XL polymerase buffer, and 2 μL of 2.5 U/μL KOD XL polymerase. The sample 
was primer-extended then cycled 10 times according to the following PCR program: 94 °C for 2 
min, 47 °C for 2 min, 72 °C for 60 min; then 94 °C for 2 min, 10× (94 °C for 1 min, 47 °C for 1 
min, 72 °C for 1 min), 72 °C for 5 min. KOD XL polymerase was removed by phenol/chloroform 
extraction. For the 30-cycle PCR, a 50 μL sample was prepared containing 1 μL of the 10-cycle 
PCR product, 25 pmol of forward primer, 100 pmol of reverse primer, 10 nmol of each dNTP, 10 
μCi of α-32P-dCTP (800 Ci/mmol), 5 μL of 10× Taq polymerase buffer, and 1 μL of Taq 
polymerase (no modified nucleotides are being incorporated in the 30-cycle PCR step). This 
sample was cycled 30 times according to the following PCR program: 94 °C for 2 min, 30× (94 °C 
for 30 s, 47 °C for 30 s, 72 °C for 30 s), 72 °C for 5 min. The sample was separated by 8% PAGE, 
and the single-stranded reverse complement was isolated for subsequent primer extension. 
Procedure for primer extension with modified 2′-deoxyuridine 5′-triphosphates to 
regenerate pool size in subsequent in vitro selection rounds. A 25 μL sample was prepared 
containing the reverse complement template, 50 pmol of forward primer, 7.5 nmol each of dATP, 
dCTP, dGTP, and modified dUTP, 10 μCi of α-32P-dCTP (800 Ci/mmol), 2.5 μL of 10× KOD XL 
polymerase buffer, and 0.5 μL of KOD XL polymerase. Primer extension was performed by 
cycling in a PCR thermocycler according to the following program: 94 °C for 2 min, 47 °C for 2 
min, 72 °C for 60 min. The product was purified by 8% PAGE. 
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Chapter 4: In Vitro Selection of Deoxyribozymes for 
3-Nitrotyrosine Modification 
4.1 Introduction 
4.1.1 Biological Role of 3-Nitrotyrosine 
Amino acid side chains on proteins are occasionally altered further by post-translational 
modifications. Tyrosine side chains can undergo phosphorylation, sulfation, and nitration in 
various physiological and pathological processes. Tyrosine phosphorylation and sulfation are 
regulated by tyrosine kinase and tyrosylprotein sulfotransferase enzymes, respectively. In contrast, 
nitration of tyrosine occurs spontaneously, often while the cell is under oxidative stress.1 
Reactive oxygen species (ROS) and reactive nitrogen species (RNS) are natural byproducts 
of aerobic metabolism. The commonly oxidized side chains of proteins are cysteine, methionine 
tryptophan, and tyrosine. Oxidation at cysteine and methionine residues happens under regular 
cellular conditions and is generally reversible.2 The oxidation of tyrosine to 3-nitrotyrosine occurs 
under severe oxidative stress and is irreversible. Consequently, it plays an important role in 
signaling that the cell is in distress. An example is when activated macrophages produce nitric 
oxide as part of the immune response (Figure 4.1).3 Nitric oxide reacts with tyrosine to form 3-
nitrotyrosine, which feeds into downstream signaling pathways. 
 
Figure 4.1. Cellular production of nitric oxide and other RNS during the inflammation process. 
Figure reprinted with permission from ref. 3. 
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4.1.2 3-Nitrotyrosine Detection 
3-Nitrotyrosine is stable but occurs at extremely low abundance (typically around 0.01%–
0.0001%), even in cells under oxidative stress.4 Furthermore, non-nitrated peptides can suppress 
the signals of 3-nitrotyrosine peptides in analytical methods such as mass spectrometry, which 
makes the detection and quantification of 3-nitrotyrosine modifications on proteins a difficult 
task.5,6 Many common methods rely on an indirect route: the free amino groups on the proteins are 
first masked, and then the nitro groups on 3-nitrotyrosines are reduced to amines, tagged, and 
enriched (Figure 4.2).7 Another option is to perform Western blotting with commercially available 
anti-3-nitrotyrosine antibodies.2 We sought to develop artificial enzymes with 3-nitrotyrosine 
specificity that may support a useful alternative over conventional methods of 3-nitrotyrosine 
detection. 
 
Figure 4.2. Example process for 3-nitrotyrosine detection. The initial blocking step is necessary 
to prevent interference from the abundant free amines on the peptide. Figure reprinted with 
permission from ref. 7. 
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4.1.3 Deoxyribozymes for Tyrosine Modification 
Previous research in the Silverman lab identified deoxyribozymes that catalyze tyrosine 
azido-adenylylation, which is the transfer of the 2′-azido-2′-deoxyadenosine 5′-monophosphoryl 
group (2′-Az-dAMP) from 2′-azido-2′-deoxyadenosine 5′-triphosphate (2′-Az-dATP) onto the 
tyrosine hydroxyl group.8 The azido-adenylylated peptides are further modified using the azide 
handle and an alkyne reagent, such as PEG-alkyne (Figure 4.3). Some of the deoxyribozymes 
demonstrated peptide sequence specificity, while others were sequence-general. Therefore, we 
were interested to attempt the identification of deoxyribozymes that specifically catalyze the azido-
adenylylation of 3-nitrotyrosine but not tyrosine. We hypothesized this to be possible despite the 
lower nucleophilicity of the oxygen on 3-nitrotyrosine compared to tyrosine. 
 
Figure 4.3. Schematic diagram of the in vitro selection process for the identification of 
deoxyribozymes for tyrosine azido-adenylylation. Figure reprinted with permission from ref. 8. 
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4.2 Results and Discussion 
4.2.1 Peptide Substrate Preparation 
Fmoc-3-nitrotyrosine was used in solid-phase synthesis without side chain protection for 
its hydroxyl group. The low nucleophilicity prevented the formation of branched products while 
using standard Fmoc coupling procedures. However, the hydroxyl group was acetylated under the 
capping conditions of 50 equivalents of acetic acid and 50 equivalents of diisopropylethylamine 
in DMF. The undesired side chain acetylation was removed by treatment with 20 equivalents of 
triethylamine in 90:10 water/acetonitrile, followed by neutralization with acetic acid and HPLC 
purification. Triethylamine treatment for 30 min led to 85% removal of the undesired acetyl group 
(Figure 4.4). The peaks were collected and the identities of the peptides were verified by ESI-MS 
(Section 4.4.1). The time was kept short to minimize possible base-catalyzed epimerization of the 
peptide.9 
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Figure 4.4. Deprotection of 3-nitrotyrosine side chain acetylation by triethylamine, assayed by 
HPLC. The product is Ac-CLQTY*PRT-NH2, where Y* denotes 3-nitrotyrosine, and the substrate 
is acetylated at the side chain hydroxyl group of 3-nitrotyrosine. 
4.2.2 Tyrosine Azido-Adenylylation Deoxyribozymes 
We tested nine tyrosine azido-adenylylation deoxyribozymes, DzAz1–DzAz9, with 
3-nitrotyrosine peptide substrates each covalently attached to a radiolabeled 19 nt anchor. Six of 
the nine deoxyribozymes had no activity when the tyrosine residues in their respective peptide 
substrates were replaced with 3-nitrotyrosine, while three of the nine deoxyribozymes displayed 
low levels of activity (DzAz2, DzAz7, and DzAz8; Figure 4.5). This indicated that DNA can 
catalyze the azido-adenylylation of 3-nitrotyrosine at least to a small extent. More efficient 
deoxyribozymes may emerge from in vitro selection when 3-nitrotyrosine is used as the substrate 
throughout the process. 
120 min 
30 min 
5 min 
← product 
← substrate 
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Figure 4.5. Assay of azido-adenylylation deoxyribozymes DzAz2, DzAz7, and DzAz8 for 
3-nitrotyrosine activity. See Table 4.1 for peptide sequences. Positive controls (+) were incubated 
for 12 h with the original tyrosine peptides as substrates. Negative controls (−) were incubated for 
12 h in the absence of 2′-Az-dATP. 
deoxyribozyme 3-nitrotyrosine substrate positive control 
DzAz1 Ac-CAAY*AA-NH2 Ac-CAAYAA-NH2 
DzAz2 
Ac-CLQTY*PRT-NH2 Ac-CLQTYPRT-NH2 
DzAz3 
DzAz4 
DzAz5 
DzAz6 
DzAz7 
Ac-CERSY*LMK-NH2 Ac-CERSYLMK-NH2 DzAz8 
DzAz9 
 
Table 4.1. Peptide substrates for 3-nitrotyrosine azido-adenylylation assay (Y* = 3-nitrotyrosine). 
4.2.3 In Vitro Selection Strategy 
 In pursuit of deoxyribozymes for 3-nitrotyrosine modification, we employed the same 
strategy used in the in vitro selection for tyrosine modification, with 3-nitrotyrosine in place of 
tyrosine in the peptide substrates.8 Starting from the upper left image of Figure 4.6, the peptide 
substrates were covalently attached to a DNA anchor oligonucleotide via a disulfide linkage and a 
hexa(ethylene glycol) [HEG] tether. Splint-assisted ligation was performed using T4 DNA ligase 
to attach the DNA-anchored peptide substrate to the initially random N40 DNA pool. The sequence 
of the DNA anchor oligonucleotide was designed to base-air with one of the fixed-sequence 
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binding arms of the DNA pool. The ligation product was isolated by polyacrylamide gel 
electrophoresis (PAGE). Next, the selection step was performed, in which the DNA sequences 
were incubated with 2′-Az-dATP and divalent metal ions in a buffered solution to enable DNA 
catalysis. Active DNA sequences were further modified by CuAAC with alkyne-modified 
poly(ethylene glycol) averaging 5000 Da in mass (PEG5k-alkyne). The mass increase from this 
capture step enables PAGE separation of the catalytically active DNA sequences. 
 
Figure 4.6. In vitro selection procedure for the identification of nitrotyrosine azido-adenylylation 
deoxyribozymes. Figure adapted with permission from ref. 8. 
CuAAC capture was followed by either DTT or Glu-C endopeptidase cleavage treatment 
and an additional PAGE separation (Figure 4.7). Imposing two gel-shift requirements for the 
sequences that are isolated and carried forward to the PCR step effectively prevents the emergence 
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of DNA sequences that catalyze undesired reactions.8 In addition, this strategy was used to target 
deoxyribozymes that specifically modify 3-nitrotyrosine in the presence of tyrosine and 
independent of distance to the DNA anchor (Table 4.2). After the post-capture cleavage treatment, 
PCR was performed to amplify the DNA sequences that remain after all of the previous steps. The 
entire process was iterated, in each round enriching the population with catalytically active 
sequences. 
 
Figure 4.7. Optimization of Glu-C endopeptidase treatment conditions. The substrate was 
CERSY*LMK covalently attached to a radiolabeled 19 nt anchor. The reaction was performed in 
10 μL of 100 mM NH4HCO3, pH 8.0. 0.2 U of Glu-C was chosen as the standard condition. 
 peptide substrate post-capture treatment 
resulting mass change 
catalysis 
at Y* 
catalysis 
at Y 
catalysis 
elsewhere 
odd rounds C-LQTY*PRT-E-LQTYPRT DTT large loss large loss negligible 
even rounds C-LQTYPRT-E-LQTY*PRT Glu-C large loss negligible negligible 
 
Table 4.2. Post-capture DTT or Glu-C treatment as a strategy to avoid DNA sequences that 
catalyze undesired reactions, using as an example the AF2 in vitro selection experiment (see main 
text below for description). The desired reaction is azido-adenylylation at Y*. DNA sequences that 
perform catalysis at Y instead are separated by Glu-C treatment during even rounds. 
Three groups of in vitro selection experiments were performed, using various DNA anchor 
oligonucleotide sequences and peptide substrates (Section 4.4.1). The anchor sequences were 
chosen to differ from the ones used in the in vitro selection experiments for tyrosine azido-
adenylylation to avoid contamination by previously identified deoxyribozymes. 
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The first group of in vitro selection experiments (designated as AD2-AJ2) used 16 aa 
peptides comprised of two heptapeptide segments joined by a glutamic acid residue, with an 
additional cysteine residue at the N-terminus to form the disulfide linkage with the DNA anchor. 
One of the heptapeptide segment contained a 3-nitrotyrosine, and the other heptapeptide segment 
contained a tyrosine. The goal of this experimental setup was to identify deoxyribozymes that 
specifically modify 3-nitrotyrosine in the presence of tyrosine.  For some of the in vitro selection 
experiments (AF2-AJ2), the location of the 3-nitrotyrosine-containing heptapeptide segment was 
alternated between odd and even rounds as a selection pressure to favor deoxyribozymes that do 
not require close substrate proximity with the DNA anchor. The glutamic acid provides the 
cleavage site for Glu-C to enable the differentiating strategy during the even rounds as described 
above. No detectable activity (<0.5%) was observed after 14 rounds, and further experiments were 
designed. 
The second group (EN2-EQ2) used peptides containing only 3-nitrotyrosine as the 
substrate (CAAY*AA, CLQTY*PRT, and CERSY*LMK). We expected the DNA sequences to 
engage the CAAY*AA peptide without having to bind to the neighboring amino acid side chains. 
The third group (EK2-EM2) was a redirection of previous in vitro selection experiments for 
tyrosine azido-adenylylation, and used partially randomized sequences of the DzAz2, DzAz7, and 
DzAz8 deoxyribozymes as the starting DNA pools, with 3-nitrotyrosine in place of tyrosine in the 
corresponding peptide substrates. No detectable activity was observed after 14 rounds, and the 
experiments were discontinued. 
4.3 Summary and Outlook 
The nonzero activity of DzAz2, DzAz7, and DzAz8 with 3-nitrotyrosine peptides was 
initially encouraging. Ultimately, however, the lack of activity from even the EK2-EM2 
redirection experiments showed 3-nitrotyrosine modification to be more difficult than anticipated. 
Due to the nature of the PEG5k-alkyne capture step, one possibility is that the pool might have 
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reached a low amount of catalytic activity in the later rounds, but the capture product was 
distributed too thinly over the polyacrylamide gel to be observable. 
Our hypothesis is that the nucleophilicity of the phenol oxygen on 3-nitrotyrosine is too 
low for effective reaction, due to the resonance structure of the anion that puts the negative charge 
on the neighboring nitro group instead of the phenoxide oxygen. Our experimental results suggest 
that this factor overrides the pKa effect (pKa = 10 for tyrosine and 7 for 3-nitrotyrosine), which 
causes the phenoxide to be present in a greater fraction for 3-nitrotyrosine. 
4.4 Materials and Methods 
4.4.1 Substrate Preparation Procedures 
Oligonucleotides and reagents. DNA oligonucleotides were purchased from Integrated 
DNA Technologies (Coralville, IA) or prepared by solid-phase synthesis on an ABI 394 instrument 
using reagents purchased from Glen Research. All oligonucleotides were purified by 7 M urea 
denaturing PAGE with 1× TBE (89 mM each of Tris and boric acid, 2 mM EDTA, pH 8.3), 
extracted from polyacrylamide with TEN buffer (10 mM Tris, pH 8.0, 1 mM EDTA, 300 mM 
NaCl) and precipitated with ethanol prior to use, as described previously.10,11 2′-Az-dATP was 
purchased from TriLink BioTechnologies (San Diego, CA). PEG5k-alkyne was purchased from 
Laysan Bio (Arab, AL). 
Solid-phase peptide synthesis. Amino acid monomers were purchased from Chem-Impex 
(Wood Dale, IL). Peptides were prepared by Fmoc solid-phase synthesis on Rink amide MBHA 
resin using N,N,N′,N′-tetramethyl-O-(7-azabenzotriazol-1-yl)uronium hexafluorophosphate 
(HATU) as the coupling agent. Each synthesis was performed on a 0.2 mmol scale, using 0.26 mg 
of Rink amide resin with a loading capacity of 0.77 mmol/g. Peptide coupling procedures were 
performed as previously described.12 
Peptide deprotection, purification, and mass spectrometry verification. After standard TFA 
cocktail treatment for cleavage from the resin, the crude peptides were dissolved in 90:10 
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water/acetonitrile. To this solution 20 equivalents of triethylamine was added and the solution was 
vigorously mixed for 30 min. 20 equivalents of acetic acid was added to neutralize the solution, 
and the peptide was purified by HPLC [Shimadzu Prominence instrument; Jupiter Proteo C18 
column, 4 μm, 10 × 250 mm; gradient of 5% solvent A (acetonitrile) and 95% solvent B (0.1% 
trifluoroacetic acid in water) at 0 min to 45% solvent A and 55% solvent B at 60 min with flow 
rate of 2.0 mL/min]. Low-resolution ESI mass spectrometry data were obtained on a Waters 
Quattro at the UIUC School of Chemical Sciences Mass Spectrometry Laboratory. 
ESI-MS: m/z calcd. for Ac-CLQTY*(OAc)PRT-NH2 C46H72N14O16S [M+H]+ 1109.5; found 
1109.2. 
ESI-MS: m/z calcd. for Ac-CLQTY*PRT-NH2 C44H70N14O15S [M+H]+ 1067.5; found 1068.4. 
ESI-MS: m/z calcd. for Ac-CERSY*(OAc)LMK-NH2 C47H76N14O16S2 [M+H]+ 1157.5; found 
1157.2. 
ESI-MS: m/z calcd. for Ac-CERSY*LMK-NH2 C45H74N14O15S2 [M+2H]2+ 558.2; found 558.8. 
Synthesis of DNA-anchored peptide conjugates. DNA-anchored peptide conjugates were 
synthesized by disulfide bond formation between a DNA HEG-tethered 5′-thiol and the N-terminal 
cysteine side chain of the peptide substrates (Table 4.3 and 4.4), following reported procedures.12 
The 5′-thiol DNA anchor oligonucleotide was 5′-HO-C6-S-S-C6-p-HEG-X-3′, where X represents 
the specific oligonucleotide sequence (Table 4.5). A 5′-disulfide linker was introduced via standard 
solid-phase DNA synthesis and unmasked to the thiol by DTT reduction. The free thiol was 
activated as the pyridyl disulfide by treatment with 2,2′-dipyridyl disulfide in DMF. The activated 
DNA substrate was coupled with the free thiol of the peptide N-terminal Cys, forming the 
DNA-anchored peptide conjugate. The DNA anchor was ligated to the pool with T4 DNA ligase 
in a splint-assisted reaction. All steps were performed as previously described.8, 13 
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In vitro selection with 3-nitrotyrosine and tyrosine in various sequence contexts 
in vitro selection 
experiment 
odd rounds even rounds 
peptide substrate post-capture treatment peptide substrate 
post-capture 
treatment 
AD2 C-LQTY*PRT-E-LQTYPRT DTT same as odd rounds 
AE2 C-LQTYPRT-E-LQTY*PRT Glu-C same as odd rounds 
AF2 C-LQTY*PRT-E-LQTYPRT DTT C-LQTYPRT-E-LQTY*PRT Glu-C 
AG2 C-QRSY*LMK-E-QRSYLMK DTT C-QRSYLMK-E-QRSY*LMK Glu-C 
AH2 C-LQTY*PRT-E-QRSYLMK DTT C-QRSYLMK-E-LQTY*PRT Glu-C 
AJ2 C-QRSY*LMK-E-LQTYPRT DTT C-LQTYPRT-E-QRSY*LMK Glu-C 
 
Table 4.3. Peptide substrates for the AD2-AJ2 in vitro selection experiments. The alternating post-
capture treatment strategy allowed us to target azido-adenylylation at 3-nitrotyrosine in the 
presence of tyrosine, as described in Section 4.2.3. 
 
in vitro selection 
experiment peptide substrate 
In vitro selection with single 3-nitrotyrosine peptide 
EN2 C-AAY*AA 
EP2 C-LQTY*PRT 
EQ2 C-ERSY*LMK 
In vitro selection with partially randomized pools from DzAz2, DzAz7, and DzAz8 
EK2 C-LQTY*PRT 
EL2 
C-ERSY*LMK 
EM2 
 
Table 4.4. 3-Nitrotyrosine peptide substrates for the EN2-EQ2 and the EK2-EM2 selection 
experiments. 
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in vitro selection 
experiment DNA anchor sequence and pool sequence 
in vitro selection with 3-nitrotyrosine and tyrosine in various sequence contexts 
AD2 
TATCTTAGCCGTTTTAAGGGGTAGTCCTAGTCGATAAAACGGCTAAGATA-N40-CTTAGAAAATAGTGAAGC AE2 
AF2 
AG2 TATCGACCCCACGGATAGGGGTAGTCCTAGTCGAATCCGTGGGGTCGATA-N40-CTTACCTCACGAGGAAGC 
AH2 
TATCCTCTGCCCGTTGAGGGGTAGTCCTAGTCGACAACGGGCAGAGGATA-N40-CTTAAAATCGCAACAAGC 
AJ2 
in vitro selection with single 3-nitrotyrosine peptide 
EN2 TATCCCTACACGATCTAGGGGTAGTCCTAGTCGAAGATCGTGTAGGGATA-N40-CTTTGAAAAATCTAAAGC 
EP2 TATCTTAGCCGTTTTAAGGGGTAGTCCTAGTCGATAAAACGGCTAAGATA-N40-CTTAGAAAATAGTGAAGC 
EQ2 TATCGACCCCACGGATAGGGGTAGTCCTAGTCGAATCCGTGGGGTCGATA-N40-CTTACCTCACGAGGAAGC 
in vitro selection with partially randomized pools from DzAz2, DzAz7, and DzAz8 
EK2 TATGCGTATTTCCATCAGGGGTAGTCCTAGTCGAGATGGAAATACGCATA-N40-CTTTCTCCGAAAGCAAGC 
EL2 TATTAATCATTGGACTAGGGGTAGTCCTAGTCGAAGTCCAATGATTAATA-N40-CTTAAGTCAGAATTAAGC 
EM2 TATGGTTAGTTCGGTAAGGGGTAGTCCTAGTCGATACCGAACTAACCATA-N40-CTTATAAATGAGTTAAGC 
 
Table 4.5. Oligonucleotide sequences used in the in vitro selection experiments. All sequences are 
displayed 5′ to 3′. The first 19 nucleotides comprise the DNA anchor. For the AD2-AJ2 
experiments and the EN2-EQ2 experiments, N40 denotes a random region consisting of 40 
nucleotides. For the EK2-EM2 experiments, N40 denotes a partially (25%) randomized region 
based on DzAz2, DzAz7, and DzAz8 deoxyribozymes, respectively. The reverse PCR primer for 
all sequences is (AAC)4XCCATCAGGATCAGCT and binds to the underlined regions, where X 
denotes a HEG spacer used to stop Taq polymerase. 
4.4.2 In Vitro Selection Procedures 
Procedure for ligation step in round 1. A 26 μL sample containing 500 pmol of DNA pool, 
600 pmol of DNA splint, and 750 pmol of 5′-phosphorylated DNA-anchored peptide substrate was 
annealed in 5 mM Tris, pH 7.5, 15 mM NaCl, and 0.1 mM EDTA by heating at 95 °C for 3 min 
and cooling on ice for 5 min. To this solution was added 3 μL of 10× T4 DNA ligase buffer without 
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DTT (400 mM Tris, pH 7.8, 100 mM MgCl2, and 5 mM ATP) and 1 μL of 5 U/μL T4 DNA ligase 
(Thermo Fisher). The sample was incubated at 37 °C for 12 h and purified by 8% PAGE. 
Procedure for ligation step in subsequent rounds. A 17 μL sample containing the 
PCR-amplified DNA pool (~5–10 pmol), 25 pmol of DNA splint, and 50 pmol of 
5′-phosphorylated DNA-anchored peptide substrate was annealed in 5 mM Tris, pH 7.5, 15 mM 
NaCl, and 0.1 mM EDTA by heating at 95 °C for 3 min and cooling on ice for 5 min. To this 
solution was added 2 μL of 10× T4 DNA ligase buffer without DTT (400 mM Tris, pH 7.8, 100 
mM MgCl2, and 5 mM ATP) and 1 μL of 1 U/μL T4 DNA ligase (Thermo Fisher). The sample 
was incubated at 37 °C for 12 h and purified by 8% PAGE. 
Procedure for selection step in round 1. Each in vitro selection experiment was initiated 
with 200 pmol of the ligated pool. A 16 μL sample containing 200 pmol of ligated pool was 
annealed in 5 mM HEPES, pH 7.5, 15 mM NaCl, and 0.1 mM EDTA by heating at 95 °C for 3 
min and cooling on ice for 5 min. The selection step was initiated by bringing the sample to 40 μL 
total volume containing 70 mM HEPES, pH 7.5, 40 mM MgCl2, 20 mM MnCl2, 1 mM ZnCl2, 150 
mM NaCl, and 100 μM 2′-Az-dATP. The Mg2+ was added from a 10× stock solution containing 
400 mM MgCl2. The Mn2+ was added from a 10× stock solution containing 200 mM MnCl2. The 
Zn2+ was added from a 10× stock solution containing 10 mM ZnCl2, 20 mM HNO3, and 200 mM 
HEPES at pH 7.5; this stock solution was freshly prepared from a 100× stock of 100 mM ZnCl2 
in 200 mM HNO3. The metal ion stocks were added last to the final sample. The sample was 
incubated at 37 °C for 14 h and separated by 8% PAGE. 
Procedure for selection step in subsequent rounds. An 8 μL sample containing the ligated 
pool was annealed in 5 mM HEPES, pH 7.5, 15 mM NaCl, and 0.1 mM EDTA by heating at 95 °C 
for 3 min and cooling on ice for 5 min. The selection step was initiated by bringing the sample to 
20 μL total volume containing 70 mM HEPES, pH 7.5, 40 mM MgCl2, 20 mM MnCl2, 1 mM 
ZnCl2, 150 mM NaCl, and 100 μM 2′-Az-dATP. The sample was incubated at 37 °C for 14 h and 
separated by 8% PAGE. 
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Procedure for capture step in each round. The sample from the selection step was brought 
to 20 µL total volume containing 100 mM HEPES, pH 7.5, 10 mM PEG5k-alkyne, 40 mM 
tris(3-hydroxypropyltriazolylmethyl)amine (THPTA), 10 mM sodium ascorbate, and 5 mM 
CuSO4. The four reagents were added from 100 mM (10×), 1 M (25×), freshly prepared 100 mM 
(10×), and 100 mM (20×) stock solutions, respectively, and were premixed and added to the other 
components last. The sample was incubated at 4 °C for 1 h and separated by 8% PAGE. 
Procedure for post-capture step DTT reduction. The sample from the selection step was 
brought to 20 μL total volume containing 100 mM HEPES, pH 7.5, and 50 mM DTT. The sample 
was incubated at 37 °C for 2 h and separated by 8% PAGE. 
Procedure for post-capture step Glu-C endopeptidase cleavage. The sample from the 
selection step was brought to 20 μL total volume containing 100 mM NH4HCO3, pH 8.0, and 0.2 
U of Glu-C endopeptidase. The sample was incubated at 37 °C for 30 min, Glu-C was removed by 
phenol/chloroform extraction, and the DNA sequences were separated by 8% PAGE. 
Procedure for PCR. In each selection round, two PCR reactions were performed, a 
10-cycle PCR followed by a 30-cycle PCR. For the 10-cycle PCR, a 100 μL sample was prepared 
containing the post-capture step treatment product, 200 pmol of forward primer, 50 pmol of reverse 
primer, 20 nmol of each dNTP, 10 μL of 10× Taq polymerase buffer, and 2 μL of Taq polymerase. 
The sample was cycled according to the following PCR program: 94 °C for 2 min, 10× (94 °C for 
30 s, 47 °C for 30 s, 72 °C for 30 s), 72 °C for 5 min. Taq polymerase was removed by 
phenol/chloroform extraction. For the 30-cycle PCR, a 50 μL sample was prepared containing 1 
μL of the 10-cycle PCR product, 100 pmol of forward primer, 25 pmol of reverse primer, 10 nmol 
of each dNTP, 20 μCi of α-32P-dCTP (800 Ci/mmol), 5 μL of 10× Taq polymerase buffer, and 1 
μL of Taq polymerase. This sample was cycled according to the following PCR program: 94 °C 
for 2 min, 30× (94 °C for 30 s, 47 °C for 30 s, 72 °C for 30 s), 72 °C for 5 min. Samples were 
separated by 8% PAGE. 
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